
- THE VACCINE DEATH REPORT-
ãã®ã¬ããŒãã¯ãçŸåšãäžçãæ··ä¹±ãããŠãããã¯ã¯ãã³ã«ããç倧ãªè¢«å®³ãã詳现ã«èª¿æ»ããäžçã«çå®ãäŒããŠããå ±åæžã翻蚳ãããã®ã§ãã
åæã®ææ°çã¯ã https://www.stopworldcontrol.com/report  ãããã©ãªãã§ãããŠã³ããŒãã§ããŸãã
åãŠãšããµã€ãã¯ãè±èªã ãã§ã¯ãªãããªã©ã³ãèªã§ãèšè¿°ãããŠããŸããããã¯ãæ¬ã¬ããŒãã International Criminal Court ïŒãªã©ã³ãã®ããŒã°ã«èšçœ®ãããåœéåäºè£å€æïŒã«æåºãããè³æã§ããããšã瀺åããŸãã
çãããšãå®¶æããå人ã倧åãªå€ãã®æ¹ã
ã«å
±æããŠé ãããæ
å ±ã§ãã
2021 Oct. 21
----------------------------------------------------------  以äžã翻蚳æ
芪æãªãçãããž
ç§ã¯ããŠã©ãžããŒã«ã»ãŒã¬ã³ã³å士ãšäžç·ã«ãäœçŸäžäººãã®äººã ãã¯ã¯ãã³ã®æ³šå°ã«ãã£ãŠã©ã®ããã«æ»äº¡ãããã瀺ãã¬ããŒããäœæããããã«ããã®æ°ã¶æéæžåœã«åããŠããŸããã
ãã®ã¯ã¯ãã³ã»ãã¹ã»ã¬ããŒãã¯äžçã§ãé¡ãèŠãªããã®ã§ãäœäººãæ»äº¡ããã®ããäœäººãåŸéºé害ãè² ã£ãã®ããæ¿åºã¯ã©ã®ãããªææ³ã§ãããé ãããšããŠããã®ããäžçäžã§è¡ãããŠããã¯ã¯ãã³æ¥çš®ã®è£ã«ã¯ã©ã®ãããªæå³ãããã®ããªã©ããããã®æ³šå°ã«ã€ããŠç¥ã£ãŠããã¹ãããšãã»ãŒãã¹ãŠæžãããŠããŸãã
ãŒã¬ã³ã³å士ã«å ±åæžã®ç¬¬äžçš¿ãéã£ãŠç¢ºèªããŠããã£ããšãããéåžžã«æ°ã«å ¥ã£ãŠããããããã«å€ãã®æ¹ã ã«ã·ã§ã¢ããŠããã£ããšãããããã倧åé¿ãåŒã³ãŸãããWorld Doctors Allianceãã¯ãããå€ãã®å£äœãã·ã§ã¢ããŸããã
ä»åã®ã¬ããŒãã«ã¯ãæ¿åºãããããææ®µã䜿ã£ãŠã¯ã¯ãã³ã«ããè² å·ãé ããŠããããšã確èªããè€æ°ã®å éšåçºè ã®èšŒèšããã¯ã¯ãã³ã®æ³šå°ã«ãã£ãŠç¡æ°ã®äººã ã亡ããªã£ãŠããããšãçŽæ¥ç®ã«ããè¬åå±ã®å°éå®¶ã®èšŒèšãªã©ãå€ãã®è¿œå æ å ±ãå«ãŸããŠããŸãã
ã¯ã¯ãã³ã»ãã¹ã»ã¬ããŒãã«ã¯ãé©ãã»ã©å€ãã®æ å ±ãæ²èŒãããŠãããçã®å€§éèæ®ºãè¡ãããŠããããšã瀺ããäžçã§æã匷åãªèšŒæ ãšãªã£ãŠããŸããæ°çŸäžäººã®æ»ã¯ãçæçãªç Žå£ã®æ³¢ã«éããŸãããã»ãšãã©ã®æå®³äºè±¡ã¯æ°å¹ŽåŸã«ãã衚ããªããããä»åŸæ°å¹Žéã§ãã®æ°åã¯ççºçã«å¢å ããã§ãããã
ã¯ã¯ãã³ã»ãã¹ã»ã¬ããŒããã¯çŸåšãå€ãã®èšèªã«ç¿»èš³ãããŠããããŸããªããªã³ã©ã€ã³ã§å ¬éãããäºå®ã§ãã
ä»ããããŠã³ããŒãããŠãããªãã®å°åã§äœããã®è²¬ä»»ãè² ã£ãŠãã人ãã¡ïŒæ³å·è¡æ©é¢ãæ¿æ²»å®¶ãçè·åž«ãå»åž«ãåŠæ ¡ã®è²¬ä»»è ãæåž«ãæäŒã®ç§åž«ãªã©ïŒã«éã£ãŠãã ããã
ãã®ã¬ããŒãã¯100ïŒ äºå®ã«åºã¥ããŠãããäœçŸãã®åèè³æããããŸãããã¹ãŠã®æ å ±ã確èªããããšãã§ããŸãã
ãããèŠéãããªãã§ãã ãããäžçã¯ç¥ãå¿ èŠãããã®ã§ããã¯ã¯ãã³æ»äº¡äºæ å ±åæžããããŠã³ããŒãããŠãåºãå ±æããŸãããã
https://www.stopworldcontrol.com/report
ä»ç«ã¡äžãããªããã°ãããç«ã¡äžããããšã¯ã§ããªãã§ããããç§ãã¡ã¯ä»ãè¡åããªããã°ãªããŸããã
ããããã»ãœã¬ã³ã»ã³
David Sorensen

Page 1 Â Â
å®éšçãªCOVID-19ã®æ³šå°ã«èµ·å ããäœçŸäžäººãã®æ»äº¡è
ãšéç¯€ãªæå®³äºè±¡ã®èšŒæ
DAVID JOHN SORENSEN & DR. Vladimir Zelenko MD (Version 1.0 2021幎9æ)
Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â ç® ç
æ¬å ±åæžã®ç®çã¯ãå®éšçãªmRNAéºäŒåæ²»çã®æ³šå°åŸã«ãäžçäžã§äœçŸäžäººãã®äººã
ãæ»äº¡ããäœåãã®éç¯€ãªæå®³äºè±¡ãçºçããŠããããšãèšé²ããããšã§ãããŸããåäŸã®ãªãå€§èæ®ºã®çŸå®çãªãªã¹ã¯ãæããã«ããŠããŸãã
Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â äº å®
ç§ãã¡ã¯ãç§åŠçäºå®ã®ã¿ãæç€ºããæ ¹æ ã®ãªã䞻匵ãæé€ããããšãç®æããŠããŸããããŒã¿ã¯æç¢ºã§æ€èšŒå¯èœã§ããæç€ºãããæ
å ±ã«ã¯100以äžã®åèæç®ãããããããªã調æ»ã®ããã®åºçºç¹ãšããŠæäŸãããŠããŸãã
                             å
± è¬
ããŒã¿ã«ãããšãç§ãã¡ã¯çŸåšãäžçå²äžæå€§ã®çµç¹ç倧鿮ºäººãç®æããŠããã®ãããããªããç§ãã¡ã¯ãäœåå人ãã®çœªã®ãªã人ã
ãå®ãããã«ç«ã¡äžããã®ãããããšããæ£çŸ©ãããå人çãªå©çãåªå
ãããå
±è¬ããŠããŸãã®ããäžçäžã®åŒè·å£«ã®ãããã¯ãŒã¯ã¯ããã®ç¯çœªçãªã¢ãžã§ã³ãã«å¥ä»ããŠãããã¹ãŠã®äººã
ãåçºããããã®éå£èšŽèšãæºåããŠããŸãããããŸã§å æ
ããŠãããã¹ãŠã®äººã«ãç§ãã¡ã¯èšããããä»ãªããŸã ãçå®ã®åŽãéžã¶ããšãã§ããŸããã©ãããæ£ããéžæãããŠãã ããã
Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â äž ç ã® ç¶ æ³
ãã®ã¬ããŒãã¯ç±³åœã®ç¶æ³ã«çŠç¹ãåœãŠãŠããŸãããäžçã®ä»ã®å°åã«ãåœãŠã¯ãŸããŸãããšããã®ããåãçš®é¡ã®å®éšçãªæ³šå°ãäžçäžã§äœ¿çšãããŠãããåæ§ã®æ»äº¡çãšããããã®æ°åãé ãããã®åçã®è
æã·ã¹ãã ãååšããããã§ããã§ããããç§ãã¡ã¯äžçäžã®çããã«ãã®å ±åæžãå
±æããããšããå§ãããŸãããã®å ±åæžããå
šäººé¡ã«ãšã£ãŠã®èŠéãšãªããŸãããã«ã
Page 2Â Â
å°ãªããšã5å以äžã®æ»äº¡è
æ°
<CDCã®å
éšåçºè
ã宣èªäŸè¿°æžã«çœ²å>          Â
ã¢ã¡ãªã«CDCã®VAERSããŒã¿ã«ãããšã2021幎9æ17æ¥çŸåšããã§ã«726,963人ãè³åäžãå¿äžå šãè¡æ ãè³é害ãçæ£ãçºäœãè³ã»èé«ã®ççãçåœãè ããã¢ã¬ã«ã®ãŒåå¿ãèªå·±å ç«çŸæ£ãé¢ç¯çãæµç£ãäžåŠãæ¥æ¿ãªçåäœäžãé£èŽã倱æããã«ã³ã¬ãã·ãŒãã«ã¿ãã¬ãã·ãŒãªã©ã®æå®³äºè±¡ã«èŠèãããŠããŸãã倩æåŠçãªæ°ã®é節ãªå¯äœçšã«å ããŠãCDCã®å ±åã«ãããšãå®éšçãªæ³šå°ãåããçµæã15,386人è¿ããæ»äº¡ããŠããŸãããããããžã§ãŒã³ã»ããŠãšããCDCã®å»çäžæ£çºèŠã®å°éå®¶ãããã調æ»ãããšãããæ»äº¡è æ°ã¯CDCãèªããŠããæ°åãããå°ãªããšã5å以äžå€ããšããè¡æçãªçºèŠãããŸãããå®éããã®å éšåçºè ã¯ãææã®ããŒã¿ãŒã»ããã«ããŒå士ãšã®æåã®ããåãã®äžã§ãæ»äº¡è æ°ã¯10å以äžã§ãããšè¿°ã¹ãŠããŸãããã®CDCã®å¥åº·è©æ¬ºçºèŠã®å°éå®¶ã¯å®£èªäŸè¿°æžã«çœ²åããèªåã®çºèŠãè¿°ã¹ãŠããŸããåœŒå¥³ã¯æ éã«ã...å°ãªããšã5åã®ä¿å®çãªèŠå ã«ãã£ãŠå ±åãããŠããªãããšããèšèãéžãã ããæåã«æããã«ããããã«ããã®èŠå ã¯10åã§ããå¯èœæ§ãããã以äžã¯ãã®å®£èªäŸè¿°æžã®æç²ã§ããã1
ç§ã¯éå»25幎éã§100以äžã®å»çäžæ£æ€ç¥ã¢ã«ãŽãªãºã ãéçºããŠããŸããã COVID-19ã¯ã¯ãã³ãæããã«æ£è ã®æ»äº¡ã被害ã«é¢é£ããããã«ãªã£ããšããç§ã¯ãã®åé¡ã調æ»ããããšæããŸãããVAERSïŒthe Vaccine Adverse Event Reporting SystemïŒããŒã¿ããŒã¹ã¯éåžžã«æçšã§ãããä¿å®çã«èŠãŠããã¯ã¯ãã³æ¥çš®åŸ3æ¥ä»¥å ã«çºçããæ»äº¡äŸã¯ãVAERSã§å ±åããããã®ãããå°ãªããšã5åã¯å€ããšæšå®ããŠããŸãã
CDCã®å¥åº·è©æ¬ºçºèŠã®å°éå®¶ã«ãããšãç±³åœã§ã®ã¯ã¯ãã³ã«ããæ»äº¡è æ°ã¯15,386人ã§ã¯ãªãã80,000人ãã160,000人ã®éã§ãããšã®ããšã§ãã
CDCã¯ãé床ã®ã¢ã¬ã«ã®ãŒåå¿ïŒã¢ããã£ã©ãã·ãŒïŒãªã©ããã®ä»ã®æå®³äºè±¡ã«ã€ããŠãå€§å¹ ã«éå°å ±åããŠããŸããInformed Consent Action NetworkïŒICANïŒã¯ãã¢ããã£ã©ãã·ãŒã®å®éã®çºçä»¶æ°ã¯ãCDCã䞻匵ããŠããããã50ïœ120åãå€ããšãã調æ»çµæãå ±åããŠããŸã2, 3ãããã«ãããæ°éç ç©¶è ãVAERSããŒã¿ããŒã¹ã詳现ã«èª¿ã¹ãç¹å®ã®çäŸIDã調ã¹ãããšããŸãããÂ
Page 3
ãã®çµæãå
ã®æ»äº¡èšé²ãåé€ãããŠããäŸãç¡æ°ã«èŠã€ãããäžã«ã¯åå¿ã軜床ã®ãã®ã«çªå·ãå·®ãæ¿ããããŠããã±ãŒã¹ããããŸããã圌ã¯èšããŸãã
âãã¹ãŠã®çäŸçªå·ãåæããçµæãçŽ15äžä»¶ã®çäŸãæ¶ããŠããããšãããããŸãããåé¡ã¯ããããããã¹ãŠæ»äº¡ããŠãããã©ããã§ããâ ã4
CDCãããã«é倧ãªç¯çœªè ã§ãããã¯ãæ°å¹Žåã«ç ç©¶è ãã¯ã¯ãã³ãšèªéçã®é¢é£æ§ã調æ»ããéã«ãæããã«ãªããŸããããã®çµæã確ãã«çŽæ¥çãªé¢ä¿ãããããšãããã£ãã®ã§ããããã§ãCDCã¯ã©ããããïŒç ç©¶è å šå¡ãéãŸããéšå±ã®çãäžã«å€§ããªãŽãç®±ã眮ãããŸããããã®äžã«ãèªéçãšã¯ã¯ãã³æ¥çš®ã®é¢é£æ§ãç€ºãææžããã¹ãŠæã蟌ãã ã®ã§ããããããŠã蚌æ ãé æ» ãããã®ã§ãããã®åŸãäºé²æ¥çš®ãèªéçã®åå ã«ã¯ãªããªããšããããããããç§åŠçããªè«æããPediatricãã«æ²èŒãããŸãããããããCDCã®äž»èŠãªç§åŠè ã§ãããŠã£ãªã¢ã ã»ãã³ããœã³ããã®ç¯çœªãæŽé²ããŸããã圌ã¯å ¬ã«èªããŸããã
ãç§ã¯ãã¯ã¯ãã³ã®å¯äœçšã®å¯èœæ§ã«ã€ããŠãäœçŸäžäººãã®äººã ã誀解ãããããšã«é¢ãã£ãŠããŸãããç§ãã¡ã¯ç§åŠçç¥èŠã«ã€ããŠåãã€ããã®ã§ããã 5
ã¯ã¯ãã³ã«ããæ»äº¡äºæ ãé ãããã«äœ¿ãããç¯çœªçææ³ã®ææªã®äŸã¯ãCDCã2åç®ã®æ³šå°ãã2é±éçµã€ãŸã§ã人ã¯ã¯ã¯ãã³ãæ¥çš®ãããšã¿ãªããªããšããäºå®ã§ããã€ãŸãã2åç®ã®æ³šå°ã®åã®äœé±éãããããã¯2åç®ã®æ³šå°ã®åŸã®2é±éã®éã«æ»äº¡ãã人ã¯ãã¯ã¯ãã³ãæ¥çš®ããŠããªãæ»ãšã¿ãªããããããã£ãŠã¯ã¯ãã³ã«ããæ»ãšããŠã«ãŠã³ããããªãã®ã§ããããããããšã§ã泚å°åŸã®å€§éšåã®æ»äº¡ãç¡èŠããããšãã§ããã®ã§ããããã¯ãäžçäžã®åœã ã§ãæ°ãåããªãã»ã©ã®ã¯ã¯ãã³ã«ããæ»äº¡ãé ãããã«äœ¿ãããŠãã第äžã®æ¹æ³ã§ãã6,7
30äžä»¶ã®æå®³äºè±¡Â
<ã¢ãã«ãã¯æ°åäžä»¶ã®å ±åãé ã>
ã¢ãã«ãã®å éšåçºè ã¯ããConfidential - For internal distribution onlyããšæžããã瀟å éç¥ã®ã¹ã¯ãªãŒã³ã·ã§ãããäœæããããã3ã¶æéã§30äžä»¶ã®æå®³äºè±¡ãå ±åãããããšã瀺ããŸããã
ããã«ãããããŒã ã¯COVID - 19ã¯ã¯ãã³ã®äžççãªçºå£²ããµããŒãããããã«ã3ã¶æã®éã«çŽ30äžä»¶ã®æå®³äºè±¡å ±åãš3äžä»¶ã®å»çæ å ±èŠæ±ã广çã«ç®¡çããããšãã§ããŸããã 8
Page 4 Â
   å»çæ©é¢ã§ã¯ã¯ãã³ãæ¥çš®ãã5äžäººãæ»äº¡
  <ç±³åœã§ã®æ»äº¡è
æ°ã¯ãããã25äžäººã«è¿ã>
ããŒãã¹ã»ã¬ã³ãåŒè·å£«ã¯ãã¡ãã£ã±ã¢ã»ã¡ãã£ã±ã€ãã»ãµãŒãã¹ã»ã»ã³ã¿ãŒ(CMS)ã®å éšåçºè ãããæ³šå°ãåããçŽåŸã«48,465äººãæ»äº¡ãããšããæ å ±ãåŸãŸããã圌ã¯ããã®æ»äº¡è æ°ã¯ç±³åœäººå£ã®20ïŒ ä»¥äžã§ããããšã匷調ããŸããã9    ãã®æ°åãç±³åœã®å šäººå£ã«åœãŠã¯ãããšãçŽ25äžäººã®æ»äº¡çã«ãªããŸãã
å ±åãããŠããã®ã¯1ïŒ
æªæº
<å®éã®æ»äº¡çã¯100å以äž>
ãããã®æ
å ±ãããæå®³äºè±¡ãæ»äº¡ã®æ°ã¯ãäžè¬ã«å
¬è¡šãããŠããæ°ãããã¯ããã«å€ãããšãããããŸãããããããç¶æ³ã¯ç§ãã¡ã®æ³åãã¯ããã«è¶
ããŠããŸãã2009幎ã«ããŒããŒãã»ãã«ã°ãªã ã»ãã«ã¹ã±ã¢ç€Ÿãçºè¡šããæåãªã©ã¶ãã»ã¬ããŒãã«ãããšãäžè¬çã«ã¯ã¯ãã³ã«ããæå®³äºè±¡ã®1ïŒ
ããå ±åãããŠããªãããšãæããã«ãªã£ãŠããŸãã10
å»è¬åãã¯ã¯ãã³ã«ããæå®³äºè±¡ã¯äžè¬çã§ãããå
åã«å ±åãããŠããŸããã 倿¥æ£è
ã®25ïŒ
ãå»è¬åã®æå®³äºè±¡ãçµéšããŠããŸãããé£åå»è¬åå±ïŒFDAïŒã«å ±åãããã®ã¯ãå»è¬åã®æå®³äºè±¡å
šäœã®0.3ïŒ
æªæºãé節ãªäºè±¡ã®1ïœ13ïŒ
æªæºã§ãã åæ§ã«ãã¯ã¯ãã³ã®æå®³äºè±¡ã®ãã¡å ±åãããŠããã®ã¯1ïŒ
æªæºã§ãã
å ±åãããªãçç±
<åœæ°ã誀ã£ãæ
å ±ãèŽããããŠãã>
æå®³äºè±¡ã®å ±åã1ïŒ
æªæºã§ããçç±ã¯ããŸã第äžã«ãåœæ°ã®å€§éšåãã¯ã¯ãã³ã«ããå·å®³ã«é¢ããå ±åã·ã¹ãã ã®ååšãç¥ããªãããšã§ãã第äºã«ãè£œè¬æ¥çã¯é廿°å幎ã«ããããã¯ã¯ãã³ã®å±éºæ§ã«ã€ããŠäžè¬åžæ°ã«æ
å ±ãæäŸããããšãããã¹ãŠã®å»çå°éå®¶ã«å¯ŸããŠã容赊ãªãã¡ãã£ã¢æŠäºãç¹°ãåºããŠããŸãããå±éãããæŠç¥ã®1ã€ã«ååã®åŒã³æšãŠããããäºé²æ¥çš®ã«ãã被害ã«ã€ããŠçºèšãããã¹ãŠã®ç§åŠè
ãå»åž«ãçè·åž«ã蟱ããéé£ããããã«ãã¢ã³ããã¯ãµãŒããšããåŠå®çãªã¬ããã«ãéžã°ããŸããã
Page 5
ãã®ããã«æå®³äºè±¡ã®ããŒã¿ãç©æ¥µçã«é èœããç¯çœªçãªãã£ã³ããŒã³ã®ããã«ãåœæ°ã®å€§å€æ°ã¯ã¯ã¯ãã³ã害ãåãŒãå¯èœæ§ãããããšãå
šãç¥ããªãã®ã§ãã
æ¿åºæ©é¢ãå©çšããã¯ã¯ãã³äŒæ¥ã«ãããããã¬ã³ãã¯ãäœå幎ãã®éãæå®³äºè±¡ã¯éåžžã«çšãªåºæ¥äºã§ãããšäººé¡ã«äŒãç¶ããŠããŸããããã®ãããã¯ã¯ãã³ãæ¥çš®ãã人ãéç¯€ãªæå®³äºè±¡ã«èŠèãããŠãããããéå»ã®æ³šå°ã«ãããã®ãããããªããšã¯æãããããããã®ããã«å ±åããããšããããŸããã§ããã
çŸåšã®äžç屿©ã®äžã§ãã¯ã¯ãã³ã«ã€ããŠèŠåããŠããå»çå°éå®¶ãžã®æ»æã¯ãããã«é«ãã¬ãã«ã«éããŠããŸããå»çå°éå®¶ã¯ããœãŒã·ã£ã«ã¡ãã£ã¢ããå®å
šã«æé€ããããŠã§ããµã€ãã¯ã°ãŒã°ã«ã«ã©ã³ã¯ããŠã³ãããYouTubeã®ãã£ã³ãã«ã¯ãã¹ãŠåé€ãããå€ãã®äººãè·ã倱ããããã€ãã®åœã§ã¯ãå®éšçãªã³ãããæ³šå°ã«é¢ããçå®ãæããããã«å»çå°éå®¶ã鮿ãããŠããŸãã
ããã€ãã®åœã§ã¯ãã¯ã¯ãã³ã«å察ããç§åŠè ã«ãåœå ãããªã¹ããã®ã¬ããã«ã貌ã£ãŠããŸããã¯ã¯ãã³ã«ã«ãã«ã®ç¯çœªè ãã¡ããã¯ã¯ãã³ã«ã€ããŠã®æ å ±ãé èœããããã«ãããããææ®µãè¬ããªããã°ãªããªãããšã¯æããã§ããÂ
ãã®çµæãæ°ãåããªãã»ã©ã®å»çé¢ä¿è
ãæå®³äºè±¡ã®å ±åãæãããããå¯äœçšã®éå°å ±åãããã«å©é·ããŠããŸããããã«ããããã®å±éºãªçç©åŠçç©è³ªã«ã€ããŠèŠåããŠããç§åŠçãªæ
å ±ãã人é¡ã«èŠåãçºããŠããå»åŠå°éå®¶ã®æ°ã¯ãããããå°ã蟌ããããšããç©æ¥µçãªè©Šã¿ã«ãããããããéåžžã«å§åçã§ãããã»ãšãã©éåšããŠããŸãããã®ãããå»çå°éå®¶ããæ£è
ã«äœãäœå
ã«æ³šå
¥ãããŠããããç¥ãããããšãªããæªæ€èšŒã®DNA倿޿³šå°ãæäžããããšã§ãèªåãåããŠãããªã¹ã¯ãå°ãªããšãå€å°ã¯èªèããŠããªããšããããšã¯ãäºå®äžäžå¯èœã§ããæ£è
ãããæ»äº¡ããããçæ¶¯ã«ããã£ãŠé害ãè² ã£ããããã®ãç®ã®åœããã«ããã°ãåœç¶ã責任ãåãããããšãæããæå®³äºè±¡ãå ±åããªãããäžã€ã®åæ©ãšãªããŸãã
æåŸã«ãå€ãã®å»çé¢ä¿è ã¯ã¯ã¯ãã³ã®è²©å£²ä¿é²ã®ããã«ééçãªã€ã³ã»ã³ãã£ããåãåã£ãŠããŸããäŸãã°ã€ã®ãªã¹ã§ã¯ãçè·åž«ã¯åã©ãã«éãåºããã³ã«10ãã«ãåãåããŸããããããæå®³äºè±¡ãå ±åããªãçç±ã«ãªããŸãã
Page 6
ã¯ã¯ãã³ã«é¢ãã25äžä»¶ã®ã³ã¡ã³ã
<ãã§ã€ã¹ããã¯ã§æããã«ãªã£ãæå®³äºè±¡ã®æŽ¥æ³¢>
å°å
ã®ABCãã¥ãŒã¹å±ãFacebookã§ãã¯ã¯ãã³ãåããŠããªã倧åãªäººã亡ããªã£ã話ãããŠã»ãããšåŒã³ãããŠããŸããã圌ãã¯ãã®ããšããã¥ãŒã¹ã«ãããã£ãã®ã§ãããã®çµæããŸã£ããäºæ³å€ã®ããšãèµ·ãããŸããã5æ¥éã§25äžäººä»¥äžã®äººãã³ã¡ã³ããæçš¿ããŸããããã¯ã¯ãã³ãæã£ãŠããªãæãã人ã«ã€ããŠã®ã³ã¡ã³ãã¯ãããŸããã§ãããããããããã«ã¯ã¯ã¯ãã³ãæã£ãŠããªã倧åãªäººã®ããšã§ã¯ãªããã¯ã¯ãã³ãæã£ã倧åãªäººã泚å°çŽåŸã«æ»äº¡ããããçæ¶¯ã«ããã£ãŠéå®³ãæ®ã£ããããããšãæžãããŠããã®ã§ãããã®25äžä»¶ã®ã³ã¡ã³ãã¯ã人ã
ã®éã«è¡æçãªæ»ã®æ³¢ãæŒãå¯ããŠããããšããããŠããã®æ³šå°ãå¿ãçããèŠãã¿ããããããŠããããšã瀺ããŠããŸãããã®æçš¿ã¯ããã§ã«20äžåãã·ã§ã¢ãããŠããŸãã11

Page 7

Page 8

æåŸã®ã³ã¡ã³ãã§ã女æ§ããç
é¢ã®ã¿ããªã¯ã¯ã¯ãã³åå¿ãšããŠå ±åããã®ãæããŠããããšèšããå¥ã®äººããå»è
ã¯å ±åã§ããªãããšèšã£ãŠããããšã«æ°ãã€ããŸããã
ããã¯ãç§ãå
ã«èª¬æããããšã®èšŒæ ã§ããã»ãšãã©ã®å»çé¢ä¿è
ã¯ãæå®³äºè±¡ãå ±åããããšãæããŠããããåã«è
æããŠãããã®ã©ã¡ããã§ãããã®ããã«ãã¯ã¯ãã³äºæ
ã®æ¬åœã®æç
çãäžéã«ç¥ãããŠããªãã®ã§ãã250,000以äžã®ã³ã¡ã³ãã¯ã人ã
ãæ³šå°ã«ããèŠãã¿ãå ±åããå ŽæãèŠã€ãããšã接波ãèµ·ããããšã瀺ããŠããŸãã
Page 9
ã¯ã¯ãã³ã«ããæ»äº¡è
æ°ãŸãšã
<ç§ãã¡ãèããŠãããããã¯ããã«æ·±å»ã§ãã>Â
â VAERSã¯ã2021幎9æ17æ¥æç¹ã§ã15,386äººã®æ»äº¡ãå«ã726,963ä»¶ã®æå®³äºè±¡ãå
¬è¡šããŠãã ã
â CDCã®äžæ£å°éå®¶ã¯ããã®æ»äº¡è
æ°ã¯å°ãªããšã5åããããã10å以äžã§ãããšèªããÂ
â ã¡ãã£ã±ã¢ã»ã¡ãã£ã±ã€ãã»ãµãŒãã¹ã»ã³ã¿ãŒïŒCMSïŒã®å
éšåçºã«ãããçŽ5äžäººã泚å°ã§æ»äº¡ããçµç·¯ãæããã«ãªããŸããããã®äººãã¡ã¯ç±³åœäººå£ã®20ïŒ
ã«éããªãã®ã§ããã®ããŒã¿ãå
šäººå£ã«åœãŠã¯ãããš25äžäººãæ»äº¡ããããšã«ãªãã
â 150,000ä»¶ã®å ±åãVAERSã·ã¹ãã ã«ãã£ãŠæåŠãããããåé€ããããããŠãã ã
â ã¢ããã£ã©ãã·ãŒã®å®éã®æ°ã¯ãCDCã䞻匵ããŠããæ°ã®50åãã120åã§ãã ã
â 2åç®ã®æ³šå°ãã2é±é以å
ã«æ»äº¡ãã人ã¯ã¯ã¯ãã³ã«ããæ»äº¡ãšã¯ã¿ãªãããªããããåæã®ã¯ã¯ãã³ã«ããæ»äº¡ã®å€§éšåãç¡èŠãããŠããã
â Moderna瀟ã¯ãããã3ã¶æã®éã«30äžä»¶ä»¥äžã®æå®³äºè±¡ã®å ±åãåããŸããã
â ã©ã¶ãã¬ããŒãã«ãããšãäžè¬åžæ°ããå ±åãããŠããæå®³äºè±¡ã¯ããã1ïŒ
ã«ãããªã ã
â åœæ°ã®å€§å€æ°ã¯ãã¯ã¯ãã³ã®æå®³äºè±¡ãå ±åã§ããã·ã¹ãã ã®ååšãç¥ããªãã
â ç©æ¥µçãªæ€é²ãšãããã¬ã³ãã«ãããæå®³äºè±¡ã¯çšã§ãããšåœæ°ã«äŒãã人ã
ã¯èªåã®å¥åº·åé¡ãéå»ã®æ³šå°ã«èµ·å ããŠããããšãçè§£ããŠããªãã
â ã¯ã¯ãã³ã«å察ããçºèšãããå»çé¢ä¿è
ã蟱ããããéé£ãããããšã§ãå»çé¢ä¿è
ã®å€ããæå®³äºè±¡ã®å ±åãé¿ããããã«ãªã£ãã
â æ£è
ããã®æ»ãé害ã«ã€ãªãããããªæ³šå°ãããŠããŸã£ãå Žåã責任ãåãããã®ã§ã¯ãªãããšããäžå®ããå»çé¢ä¿è
ã®å ±åãããã«åŠšããŠããŸãã
â ã³ãããã¯ã¯ãã³ã®è²©å£²ä¿é²ãæäžã®ããã«ééçãªã€ã³ã»ã³ãã£ããåãåã£ãŠããããšããå»çé¢ä¿è
ãæå®³äºè±¡ãå ±åããããšã劚ããŠããŸãã
â å©çã远æ±ããã¯ã¯ãã³ã¡ãŒã«ãŒã«ã¯ãæªæ€èšŒã®å®éšç補åãåŒãèµ·ãããŠããç Žå£ãå ±åããªãçç±ããããŸãã
â 20äžäººä»¥äžã®FacebookãŠãŒã¶ãŒããã¯ã¯ãã³ã«ããæ»äº¡ãéå·ã«ã€ããŠã³ã¡ã³ãããŠããŸãã
Page 10
äžçäžã§æ°çŸäžäººãæ»äº¡
ç§åŠçãªããŒã¿ã«ãããšãã¯ã¯ãã³ã«ããé害ã®å ±åã¯1ïŒ ã«ãæºããªããšèšãããŠããŸãã ãã®1ïŒ ã®äžã®å€§éšåã¯åœå±ã«ãã£ãŠé ãããŠããŸãã圌ãã¯ãã¯ã¯ãã³ã«ããæ»äº¡ã®å€§éšåãç¡èŠããã·ã¹ãã ãå°å ¥ããŠããŸãããããã®äºå®ãšãæ¿åºã®å éšåçºè ã«ãã£ãŠæããã«ãããããŒã¿ãåããããšãã¢ã¡ãªã«ã§ã¯äœåäžäººãã®äººã泚å°ã«ãã£ãŠäº¡ããªã£ãŠããããšãããããŸããäžçäžã§åãæ³šå°ã䜿çšããŠãããããäžçèŠæš¡ã§èŠããšãã¯ã¯ãã³ã«ããæ»äº¡è æ°ã¯ééããªãæ°çŸäžäººã«äžãããšãããããŸãã
ããã¯ãçæçãªæå®³äºè±¡ã®æŽ¥æ³¢ã«éããŸãããäžççãªã¯ã¯ãã³è²©å£²æ¥è
ã§ãããäžççãªã¯ã¯ãã³æšé²ã®åååãšãªã£ãŠãããã«ã»ã²ã€ãæ°ã¯ãBBCã®ã€ã³ã¿ãã¥ãŒã§ãã»ãšãã©ã®æå®³äºè±¡ã¯2幎åŸã«ãã衚ããªãããšè¿°ã¹ãŠããããã®ããã¯ã¯ãã³éçºã«ã¯éåžžäœå¹Žããããã®ã§ãã ã€ãŸããä»åŸæ°å¹Žéã®æ»äº¡è
ãé害è
ã®æ³¢ã¯ãææ°é¢æ°çã«å€§ãããªããšããããšã§ããç¹ã«ããŒã¹ã¿ãŒã»ã·ã§ãããã©ãã©ãåœæ°ã«æŒãä»ããããã¯ã¯ãã³ã»ãã¹ããŒãã宿œãããããã ã
äžçã®å°éå®¶ã人é¡ã«èŠå
<第äžç·ã®ç§åŠè
ãã¡ãé倧ãªèŠåãçºãã>Â
ãããã®ããŒã¿ã¯ãããŒãã«å»åŠè³ãåè³ãããªã¥ãã¯ã»ã¢ã³ã¿ããšå士ãã¯ãããšããäžçã®å°éå®¶ãã¡ã«ã人é¡å²äžæå€§ã®äžççå€§èæ®ºã®ãªã¹ã¯ã«çŽé¢ããŠãããšããé倧ãªèŠåãçºããŠããŸãã12ã mRNAæè¡ã®çºæè
ã§ãããããŒãã»ãããŒã³å士ã§ãããèªåã®æè¡ã䜿ã£ããããã®æ³šå°ã«å¯ŸããŠèŠåããŠããŸãã13,14ããŸããäžççã«èåãªç§åŠè
ã§ããGeert Vanden Bosscheæ°ïŒå
ãã€ãã®ã¯ã¯ãã³éçºäºåæé·ãUnivac瀟ã®ããŒãã»ãµã€ãšã³ãã£ãã£ãã¯ã»ãªãã£ãµãŒïŒããèªåã®ååãšãã£ãªã¢ããããŠãåæ°ãæã£ãŠã³ãããæ³šå°ã®æäžã«å察ããŠããŸããã¯ã¯ãã³éçºè
ã¯ããã®æ³šå°ã被æ¥çš®è
ã®å
ç«åãäœäžãããæ°ããäºçš®ã«å¯ŸããŠè匱ã«ãªããšèŠåããŠããŸãã16 , 17 ãç¬¬äºæ¬¡äžç倧æŠã®ããã³ãŒã¹ãçåè
ã¯ã欧å·å»è¬ååºã«æ³šå°ã®äžæ¢ãæ±ããæçŽãåºããŠããŸãããããã¯æ°ããªããã³ãŒã¹ãã§ãããšèããŠããŸãã18
Page 11
äžçã®ã¯ã¯ãã³ã«ããæ»äº¡è
æ°
<äžçã®åœã
ã§ãåãããšãèšãã>
ç±³åœã§ã®äºäŸã¯ããã®ãããªæ³šå°ã«ããç Žå£ãç©èªã£ãŠããããŸããè
æããä¿å¥æ©é¢ãšã¯ã¯ãã³ã¡ãŒã«ãŒãæå®³äºè±¡ã®å€§éšåãé èœããŠããããšã瀺ããŠããŸããããã§ã¯ãã¢ã¡ãªã«ã®ç¶æ³ã決ããŠç¹å¥ãªãã®ã§ã¯ãªãããšã蚌æããããã«ãä»ã®åœã
ã«ã€ããŠãç°¡åã«è§ŠããŠãããŸãã
欧å·é£å
欧å·é£åïŒæ¬§å·50ã«åœã®ãã¡27ã«åœã®ã¿ã§æ§æïŒã§ã¯ãEudraVigilanceã®å ¬åŒå ±åæžã«ãããšã2021幎8æ18æ¥ã®æç¹ã§ãçŽ22,000äººãæ»äº¡ãã200äžäººãå¯äœçšã«èŠãã¿ããã®ãã¡50ïŒ ãé節ã§ããããšãå ¬åŒã«èªããããŠããŸãã 1 9 , 2 0 éç¯€ã®æå³ãšã¯ïŒãæ»ã«è³ãå»åŠçäºè±¡ã«è©²åœããå Žåãçåœãè ããå Žåãå ¥é¢ãå¿ èŠãšããå Žåãå»åŠçã«éèŠãªå¥ã®ç¶æ ã«ãªãå ŽåããŸãã¯æ¢åã®å ¥é¢ãå»¶é·ããå Žåãæç¶çãŸãã¯é倧ãªé害ã»èœååªå€±ã«ãªãå ŽåããŸãã¯å 倩çãªç°åžžã»åºçæ¬ é¥ã§ããå Žåããé節ããšåé¡ãããããšããŠããŸãã
EUã®äžã§ãæãå°ããªåœã®ã²ãšã€ã§ãããªã©ã³ãã§ã¯ãè°äŒå€ã®èª¿æ»å§å¡äŒããåžæ°ãã¯ã¯ãã³ã®æå®³äºè±¡ãå ±åããããã®ãã©ãããã©ãŒã ãç«ã¡äžããŸãããããã¯æ¿åºãäž»å°ãããã®ã§ã¯ãªããã¡ãã£ã¢ã§ã泚ç®ãããŠããŸããããã®ããããªã©ã³ãåœæ°ã®å€§å€æ°ã¯ãã®ååšãç¥ããŸããããããããã®éããã圱é¿åã«ããããããããã®æ°éã®åãçµã¿ã«ã¯ããã§ã«1,600äººã®æ»äº¡è
ãš1,200人ã®å¥åº·è¢«å®³ãå ±åãããŠãããå€ãã®äººã
ãæ°žä¹
çãªé害ãè² ã£ãŠããŸããã21
è±åœïŒUNITED KINGDOMïŒ
å šåœçãªäºé²æ¥çš®ãã£ã³ããŒã³ãå§ãŸãå°ãåã«ãMHRAïŒMedicines and Healthcare Products Regulatory AgencyïŒã¯æ¬¡ã®ãããªèŠè«ãçºè¡šããã
MHRA ã¯ã倧éã«çºçãããšäºæ³ããã Covid - 19 ã¯ã¯ãã³ã®å¯äœçšïŒADRïŒãåŠçããADR ã®åå¿ããã¹ãã®è©³çްãèŠéããªãããã«ããããã®äººå·¥ç¥èœïŒAIïŒãœãããŠã§ã¢ããŒã«ãç·æ¥ã«æ±ããŠããŸããã22
Page 12
è±åœæ¿åºã¯ã倱æãè³åäžãæµç£ãå¿äžå
šã麻çºãèªå·±å
ç«çŸæ£ãªã©ãæåã®äžé£ã®æå®³äºè±¡ã®å ±åãçºè¡šããŸãããäºé²æ¥çš®ã®ç¬¬äžæ³¢ãæ¥çš®ããçŽåŸã«10äžä»¶ä»¥äžã®æå®³äºè±¡ãå ±åããããã®äžã«ã¯1260ä»¶ã®å€±æïŒå
šç²ãå«ãïŒãå«ãŸããŠããŸãã å ±åæžã®æåã®éšåã§ã¯ãCOVID-19ãã人ã
ãå®ãæåã®æ¹æ³ã¯ã¯ã¯ãã³ã§ãããšè³è³ããŠããŸããããã®åŸããããã®ã¯ã¯ãã³ãåŒãèµ·ãããŠããä¿¡ããããªãã»ã©ã®ç Žå£ã瀺ããŠããŸãããã®åœåæ§ã«ã¯åããŠããŸããŸãããã23, 24Â
ããã«ãè±åœåœå®¶çµ±èšå±ã¯ã2021å¹Žã®æåã®6ã¶æéã«ã30,305äººãæ³šå°ãåããŠãã21æ¥ä»¥å ã«æ»äº¡ããããšã誀ã£ãŠæããã«ããŸãã26ããŸãã35幎ã®çµéšãæã€è±åœã®ç§åŠè ããè±åœã®ã€ãšããŒã«ãŒãå ±åã·ã¹ãã ã詳现ã«åæãããã®ä¿¡é Œæ§ãäœãããšãçºèŠããŸãããã27
ãã€ãšããŒã»ã«ãŒãå ±åå¶åºŠã¯ãCOVID-19ã¯ã¯ãã³ã®å¯äœçšã®å¯èœæ§ã«ã€ããŠè±åœã®äžè¬åžæ°ã«æ³šæãä¿ãã®ã«æçšãªéå®çãªæ å ±ãæäŸã§ãããšçµè«ã¥ããããšãã§ããŸãããããããã®å¶åºŠãå®éçãªãã®ã§ã¯ãªããçŽç²ã«èšè¿°çãªãã®ãšããŠåœåããèããŠãããããè±åœã®äžè¬åžæ°ã«ãšã£ãŠæ¥µããŠéèŠãªçã®åé¡ã«å¯ŸåŠããããšãã§ããŸããã ãã®åé¡ãšã¯ãPFã¯ã¯ãã³ãAZã¯ã¯ãã³ã®æ¥çš®ãšãæ»äº¡ãªã©ã®é節ãªå¯äœçšãšã®éã«å æé¢ä¿ããããã©ããããããšããã°ãã®åœ±é¿ã®å€§ããã¯ã©ã®çšåºŠãããšããããšã§ãããÂ
ã€ã¹ã©ãšã«
ã€ã¹ã©ãšã«äººæ°å§å¡äŒã¯ãå»åž«ãåŒè·å£«ãç¯çœªåŠè
ãç«åŠè
ãåŠè¡ç ç©¶è
ãããªãããŒã ã§ãããå
¬è¡ã®å©çã®ããã«èª¿æ»ãæ¢æ±ãæŽé²ãè¡ãããšã決æããŠããŸãã圌ãã¯æ¯èŒçç¥ãããŠããªãã°ã«ãŒãã§ãããããã§ã2021幎8æ5æ¥æç¹ã§480人以äžã®æ»äº¡è
ãå«ã3754ä»¶ã®å ±åãåããŠããŸã28ãIPCã¯ããããã®æ°åã¯äººå£ã«ãããçã®æç
çã®2ïœ3ïŒ
ã«éããªããšããŠãããã€ã¹ã©ãšã«ã«ãããæ»äº¡è
æ°ã¯çŽ48,000人ãæå®³äºè±¡ã¯çŽ375,400人ãšããããšã«ãªããŸãã ãŸããã€ã¹ã©ãšã«ã§ã¯ãWorldometers.infoã®çµ±èšã«ãããšãäºé²æ¥çš®ãå§ãŸã£ãæã«æ»äº¡è
æ°ãæ¥å¢ããŠããŸããäºé²æ¥çš®ãå§ãŸãåã®ã€ã¹ã©ãšã«ã§ã¯ãæ¯æ¥ã®ããã«ã³ãããã®æ»äº¡è
ãåºãããšã¯ã»ãšãã©ãããŸããã§ãããäºé²æ¥çš®ãå§ãŸããšã1æ¥ã®æ»äº¡è
æ°ã1ïœ3人ãã75ïœ100人ã«å¢ããã®ã§ãã
Page 13

ã¯ã¯ãã³ã«ãã被害ãå ±åããŠããã€ã¹ã©ãšã«ã®ãŠã§ããµã€ãã«ã¯ãSeethetruth.club/covid-19-vaccine-victims ããããããã§ã¯äºé²æ¥çš®ã«ãã£ãŠå€§ããªè¢«å®³ãåãã人ã
ã®ç¡æ°ã®èšŒèšãèŠãããšãã§ããŸããã¢ã¡ãªã«ã§ã¯ãã1000covidstories.comããšããåæ§ã®ãµã€ãã§ãã³ãããæ³šå°ã§æ»äº¡ãã人ãé節ãªåå¿ã瀺ãã人ãã¡ã®ãããªãå¢ãç¶ããŠããŸãããŸãããTheCovidWorld.comããšãããµã€ãã§ã¯ãã³ãããæ³šå°ã§æ»äº¡ããå€ãã®äººã
ã®å人çãªäœéšè«ã玹ä»ãããŠããŸãããã®ããã«ãäœå人ãã®äººã
ãäºé²æ¥çš®åŸã®èŠãã¿ãåãã¡åããšããããšã¯ãæŽå²äžåããŠã®ããšã§ããããšãçè§£ããªããã°ãªããŸããããªããã®ãããªããšãèµ·ããã®ããšãããšãç¯çœªè
ã§ãããä¿å¥æ©é¢ããèšããããªãé çãããŸããã€ã³ãã«ãšã³ã¶ã®ãããªçç¶ããšã¯å
šãéãå¯äœçšãèµ·ããããã§ããå¯äœçšã¯éåžžã«éããçæ¶¯ã«ããã£ãŠèº«äœé害è
ãšãªãããšãå€ãã®ã§ããããŸãã«ãéçãªã®ã§ãäžçäžã®äººã
ã人é¡ã«èŠåãçºããŠããã®ã§ãã
ãã©ãžã«
ãã©ãžã«ã§ã¯ã5ã¶æéã§32,000人ã®ã¯ã¯ãã³ã«ããæ»äº¡ã確èªãããŠããŸãããã®ã¬ããŒãã¯uol.com.brã«æ²èŒãããŠãããSimilarWebã®ããŒã¿ã«ãããšãuol.com.brã®ããŒãžãã¥ãŒã¯CNN.comãšã»ãŒåãã§ãããšããããã®ããã«ã¯ã¯ãã³æ¥çš®åŸã®æ»äº¡è
æ°ãå€ãã«ãããããããå ±åæžã¯ããè¿°ã¹ãŠããŸããã¯ã¯ãã³æ¥çš®ã¯äŸç¶ãšããŠç
æ°ãã³ã³ãããŒã«ããããã®æè¯ã®æ¹æ³ã§ããããšããŠããŸãã 29
Page 14
ã¯ã¯ãã³ã®è¢«å®³ãç§åŠã蚌æ
<è³åäžãå¿èçºäœããã>
ãµã³ãã©ã³ã·ã¹ã³å€§åŠããŸãã¯ãœãŒã¯ç ç©¶æã®ç ç©¶ã«ãããšãã¯ã¯ãã³ã¯äººäœãã¹ãã€ã¯ã»ã¿ã³ãã¯å·¥å Žã«å€ããè³åäžãå¿èçºäœã®åå ãšãªãè¡æ ã®åå ãšãªãäœå
ãã®ã¹ãã€ã¯ãäœãããšãããã£ãŠããŸãã30 ããŸãå¥ã®ç ç©¶ã§ã¯ãã¯ã¯ãã³ãèŽåœçãªè¡æ ãåŒãèµ·ããããããå¿èçºäœãè³åäžã®åå ãšãªãããšã確èªãããŠããŸãã31 ,3 2ã ãã¥ãŒã€ã³ã°ã©ã³ãã»ãžã£ãŒãã«ã»ãªãã»ã¡ãã£ã·ã³ã«ãããšããžã£ããå¿èã®ççãåŒãèµ·ããããšãããã£ãŠããŸãã33 ããŸããåããžã£ãŒãã«ã«ã¯æµç£ã®æ¿å¢ã«é¢ããç ç©¶ãæ²èŒãããŠããŸãã34 ãããã€ãã®ç ç©¶ã§ã¯ãæäœäŸå匷åã®å®æ
ã蚌æãããŠããŸãã35 , 36 , 37 ããŸããäžåŠçã®çºçãç²Ÿåæ°ã®æžå°ã確èªãããŠããŸãã38 , 39 ãæåŸã«ã泚å°ãçãåŒãèµ·ãããšããç ç©¶çµæãåºãŠããŸãã40ã ãããã¯ã»ãã®äžäŸã§ãã
äžåœã«è²¬ä»»ãå
ãã
<ã¯ã¯ãã³ã¡ãŒã«ãŒã¯è²¬ä»»ãè² ããªã>Â
é廿°å幎ã®éã«ãäžçäžã®åœã
ã§ããã€ãã®å
¬åŒãªæ¿åºåå®ãçµã°ãããã¹ãŠã®ã¯ã¯ãã³ã¡ãŒã«ãŒããã¹ãŠã®è²¬ä»»ãã100ïŒ
ä¿è·ãããããšã«ãªããŸããã圌ãã®è£œåãã©ãã»ã©ã®è¢«å®³ããããããŠãã誰ã責任ãåãããšã¯ã§ããªãã®ã§ãããã®äžãã¯ã¯ãã³è¢«å®³ã«ããè²»çšã¯ãã©ã®å¥åº·ä¿éºã§ãã«ããŒãããŸãããã¯ã¯ãã³ãåãã人ããã©ãã«ã«å·»ã蟌ãŸããŠããä¿éºã§ã¯è£åãããªãã®ã§ããããããããªãã®å¥åº·ã人çãæãã人ãã¡ãç Žå£ãããå¯èœæ§ããããªããå®ãããšãæåŠããŠããåãæ¿åºãããããã®èŽåœçãªæ³šå°ã矩åã¥ããè²·ãç©ãæ
è¡ãéäŒãããã«ã¯éè¡ãµãŒãã¹ã«ãŸã§èŠæ±ããŠããã®ã§ãã
ãã®ã¯ã¯ãã³æ³šå°ã¯å¹æãããã®ãïŒ
<ä¿å¥çã¯å¹æããªããšèšã>
äžççã«æåãªã¯ã¯ãã³éçºè
ã§ããã²ã«ãã»ãã³ãã³ã»ããã·ã§å士ã¯ããã®æ³šå°ã¯äœã®å
ç«ã·ã¹ãã ãç Žå£ããã¯ã¯ãã³ãæ¥çš®ããäººãæ°ããç
æ°ã«ãããããããªããšèŠåããŠããŸãã ã41 Â
Page 15
ãææåã®é«ãäºçš®ã®ãã³ãããã¯ã®éã«è¡ããã倧éã®ã¯ã¯ãã³æ¥çš®ãã£ã³ããŒã³ã¯ããŠã€ã«ã¹ã®ææãæå¶ããããšãã§ããªãã矀éå
ç«ã®æ§ç¯ã«è²¢ç®ããã©ãããã矀éå
ç«ã®èªç¶ãªç¢ºç«ã倧å¹
ã«é
ãããããšã«ãªããããããçŸåšè¡ãããŠããçµ±äžçãªã¯ã¯ãã³æ¥çš®ãã£ã³ããŒã³ããå
¬è¡è¡çãšäžçè¡çã«ãšã£ãŠçµ¶å¯Ÿçã«æå®³ã§ããçç±ã§ããã ã42
ããŒãã«å»åŠè³ãåè³ãããªã¥ãã¯ã»ã¢ã³ã¿ããšå士ã¯ããããã®ã¯ã¯ãã³ãå±éºãªæ°çš®ãçã¿åºããŠãããšèŠéã鳎ãããŠããŸãã43ããŸããã€ã¹ã©ãšã«ã®çµ±èšã§ã¯ãäºé²æ¥çš®ãå§ãŸã£ãŠããã³ãããã®æ»äº¡ãåçã«å¢å ããããšãæããã«ãªã£ãŠããŸãïŒæ¬ã¬ããŒãã®ååºãåç
§ïŒãã€ã¹ã©ãšã«ã®ããã¿ãªã»ããããéŠçžã¯ãçŸåšæããªã¹ã¯ãé«ãã®ã¯ãã¯ã¯ãã³ã2åæ¥çš®ãã人ãã¡ã ãšèšã£ãŠããŸããã44
å³¶åœã®ã»ã€ã·ã§ã«ã§ã¯ãã³ãããã«ããæ»äº¡äŸã¯ã»ãšãã©ãããŸããã§ããããã¯ã¯ãã³æ¥çš®ãéå§ãããšãããæ»äº¡äŸã¯100åã«å¢ããŸããã

ãªãŒã¹ãã©ãªã¢ã§ã¯ãããè¥ã倫婊ããå®å šã«ã¯ã¯ãã³ãæ¥çš®ããŠããã«ãããããããçãŸããã°ããã®èµ€ã¡ãããšã®é¢äŒã8æ¥éãæåŠãããŸããããã®é人éçãªç¶æ³ã«ã€ããŠããªãŒã¹ãã©ãªã¢ã®æé«ä¿å¥è²¬ä»»è ã§ãããžã£ãããã»ã€ã³ã°å士ã¯ã次ã®ããã«æå¿«ã«èª¬æããŠãããã45
ãã¯ã¯ãã³ãæ¥çš®ãããããšãã£ãŠãææããªããšã¯éããŸãããã ããããããã®å®¶æãèµ€ã¡ããã«äŒãã«è¡ãããšã¯ã§ããªãã£ãã®ã§ããã
Page 16
ã¢ã³ãœããŒã»ãã¡ãŠãã¯æ¬¡ã®ããã«æèšããŠããŸãããCDCã¯ã¯ã¯ãã³æ¥çš®è ã«ãã¹ã¯ã矩åä»ããããšãæ€èšããŠããã46   ãã¯ã¯ãã³æ¥çš®è ã¯ãŸããŸãã³ãããã®éœæ§åå¿ã瀺ãããã«ãªãã®ã§ããã¹ã¯ãççšãç¶ããå¿ èŠãããã47   ãã¯ã¯ãã³æ¥çš®è ã¯äŸç¶ãšããŠã¬ã¹ãã©ã³ã§ã®é£äºãé¿ããå¿ èŠãããã48
ãã¯ã¯ãã³æ¥çš®è ã¯ã¯ã¯ãã³ãåããŠããªã人ãšåæ§ã«ãã«ã¿åãä¿æããŠãããã49   ã€ãŸããã¡ãŠãã«ããã°ãã¯ã¯ãã³ã¯äœã®åœ¹ã«ãç«ããªããšããããšã§ãããããã圌ã¯ãã®ç¡é§ãªæ³šå°ãæ è¡ã®éã«çŸ©åä»ããããšã䞻匵ããŠããŸãã50 Â åæ§ã®ããšããè±åœã®ããªã¹ã»ãžã§ã³ãœã³éŠçžãå ¬èšããŠããŸãã  51
å人ãå®¶æãã¯ã¯ãã³ãæ¥çš®ããŠããã°ãå±å
ã§äŒãããšãã§ããã§ããããïŒãªããªããç§ãã¡ã¯ãŸã ãã®ãããªæ®µéã§ã¯ãªãã6人ãŸãã¯2äžåž¯ã®ã«ãŒã«ã®ããšãå±å€ã§å人ãå®¶æãšäŒãããšãã§ããäžçã«ããããã§ããããšãå人ãå®¶æãã¯ã¯ãã³ãæ¥çš®ããŠãããšããŠããã¯ã¯ãã³ã100ïŒ
ã®é²åŸ¡ãããŠãããããã§ã¯ãªãã®ã§ãæ
éã«ãªãå¿
èŠããããŸããÂ
Dr. J. Bar Classen å士( J. ããŒã»ã¯ã©ãã»ã³MD)ã«ãããTrends in Internal Medicineãã«æ²èŒãããç ç©¶è«æã®ã¿ã€ãã«ã¯ä»¥äžã®éãã§ãã
"ç±³åœã®COVID-19ã¯ã¯ãã³ã¯ãç§åŠçã«é©åãªãšã³ããã€ã³ãã§ããããã¹ãŠã®åå ãšãªãé床ã®çœ¹æ£çããçšããŠåæãããããã¿ã«èšåºè©ŠéšããŒã¿ã«åºã¥ããŠãåããã害ãããããããšã蚌æãããŠããã"ã
CDCã§ãããæ³šå°ã§ã¯ãã«ã¿ã»ããªã¢ã³ããä»åŸçºçããããªã¢ã³ããé²ãããšã¯ã§ããããããã£ãŠããã¹ãŠã®ã³ããã察çãç¶æããå¿
èŠããããšèªããŠãã53ããããã圌ãã¯å
šå¡ãã¯ã¯ãã³ãæ¥çš®ããªããã°ãªããªããšäž»åŒµãç¶ããŠããããªãŒã¹ãã©ãªã¢ã®ãã¥ãŒã»ãµãŠã¹ã»ãŠã§ãŒã«ãºå·ã®ããŒãã»ãã«ã¹ã»ãªãã£ãµãŒã¯ãäºèŠå¯èœãªå°æ¥ã«ããã£ãŠãç¶ç¶çãªã³ãããã®ããŒã¹ã¿ãŒæ³šå°ã®äžå®ã®ãµã€ã¯ã«ãšå
±åããæºåãããªããã°ãªããªããšè¿°ã¹ãŠãã54ãModerna瀟ã®ããŒãã»ã¡ãã£ã«ã«ã»ãªãã£ãµãŒã§ããã¿ã«ã»ã¶ãã¯ã¹å士ã¯ãã¯ã¯ãã³ã¯çæŽ»ãæ£åžžã«æ»ããã®ã§ã¯ãªããšè¿°ã¹ãŠãã55ããã®ããšã¯ãäžçä¿å¥æ©é¢ã®ãããã¹ã»ã¢ããã é·å®ãèªããŠããã56
ã¯ã¯ãã³ã ãã§ã¯ãã³ãããã¯ã¯çµãããŸããããµãŒãã€ã©ã³ã¹ãç¶ç¶ãã人ã ãæ€æ»ããéé¢ããã±ã¢ããå¿ èŠããããŸããæ¥è§Šè ã远跡ããéé¢ããå°å瀟äŒã«åããããå¿ èŠããããŸãããšè¿°ã¹ãŠããŸãã
The Lancetã«ããç ç©¶ã§ã¯ããã«ã¿åã¯ã¯ã¯ãã³æ¥çš®è
ã®éã§èªç±ã«ææããããšã瀺ãããã57ãããã¯ãããµãã¥ãŒã»ããå·Barnstableé¡ã®çºã§è€æ°ã®å€§èŠæš¡ãªå
Œ
±ã€ãã³ããè¡ãããåŸã®2021幎7æã«ã7æ3æ¥ãã17æ¥ã®éã«ãã®çºã«æ
è¡ããããµãã¥ãŒã»ããå·ã®äœæ°ã®éã§469ä»¶ã®COVID-19çäŸã確èªããã346ä»¶ïŒ74ïŒ
ïŒãå®å
šã«ã¯ã¯ãã³æ¥çš®ãåãã人ã®éã§çºçãããšããç ç©¶ã§ç¢ºèªãããã  58
Page 17
è§Šæã®ããçç©
<ã¯ã¯ãã³ã®äžã®çç©>
ãã£ãªãŒã»ãããŒãžå士ã¯ãã¢ãã«ã瀟ãšãžã§ã³ãœã³ã»ãšã³ãã»ãžã§ã³ãœã³ç€Ÿã®ã¯ã¯ãã³ã®å°ç¶ã400åã®é¡åŸ®é¡ã§èгå¯ããã圌女ãèŠããã®ã¯è¡æçã§ããã
2ã€ã®å°ç¶ã®äžã«ãè§Šæãæã£ãçç©ãããã®ã§ãããã®çç©ã¯åãåã£ãããäœãæã¡äžããããããã«ã¯èªå·±èªèããŠããããã§ãã  68A

ãã®å
æ¯ãšããã®æªç¥ã®ã¿ã³ã®ãããªçç©ããäžçäžã®äœçŸäžäººãã®åäŸãã¡ã«æ³šå°ãããŠãããšããèãã«ããããŒãžåå£«ã¯æ¶ãæµããŸãããããããããã ãã§ã¯ãããŸãããå°ç¶ã®äžã«ã¯ã°ã©ãã§ã³ãããã€ãå
¥ã£ãŠãããèªå·±çµç¹åããããç²åãèŠãããŸãããç²åã¯äºãã«ç§»åããããè€éãªæ§é ã圢æããŠããŸããã

Page 18
äžã®åçã¯ããªã©ã³ãã§éå¬ãããåŠè¡äŒè°ã§ããã¡ã€ã¶ãŒç€Ÿã®å°ç¶ãé¡åŸ®é¡ã§ã©ã€ãæ®åœ±ãããããªã§ãããã¡ã€ã¶ãŒç€Ÿã®ã¯ã¯ãã³ã®äžã«å€§ããªçç©ãå ¥ã£ãŠããŠãä»ã®å€ãã®ç²åãåãåã£ãŠããæ§åãç»é¢ã«æ ãåºãããŠããŸãã69CÂ

å±éºãªæ¯ç©
<ã°ã©ãã§ã³ãäœå
ã®é»ç£å Žãå€ãã>Â
äžççãªçç©ç©çåŠè ã§ããã¢ã³ãã¬ã¢ã¹ã»ã¯ã¬ãã«ãŒæ°ã¯ãã¯ã¯ãã³ã«å€§éã®é žåã°ã©ãã§ã³ïŒæå€§95ïŒ ïŒãå«ãŸããŠããããšãçºèŠããã
ãã®é žåã°ã©ãã§ã³ã人éã®äœå ã«æ³šå ¥ãããããšã§ãé»ç£å Žãå€åããèåšã®æ£åžžãªæ©èœãé»å®³ããããšèŠåããŠããã65
ãç§ãã¡ãå¿é
ããŠããã®ã¯ããã®ã°ã©ãã§ã³ãããããå¯äœçšã§ããããã¯å»åŠã§ã¯èª¬æãããŠããŸããããç§ã®å°éã§ããçç©ç©çåŠã§ã¯èª¬æãããŠããŸããäœãèµ·ããã®ãïŒäœãåãã«ã¯ã黿°ååã®èœåãå¿
èŠã§ããå¿èãåãã®ã¯ç£å Žãããããã§ãããã«ãã£ãŠãã³ãããã®ä»ãã¹ãŠã®ãã®ã®ããã®é»æ°ãäœãããŸããã°ã©ãã§ã³ã¯ããããŸã§ã«ãªãã£ãããã«ãé»ç£å Žãå®å
šã«å€ããŠããŸããŸããç§ãã¡ãç®ã«ããŠããã®ã¯ãåçãªå¹æããããããçäœå
ãã®ãã®ãªã®ã§ãã
Page 19
ç§ãã¡ã¯ãã¯ã¯ãã³ãæ¥çš®ããåŸã«æ»ãã§ãã人ãã¡ã®ãããªãããããèŠãŠããŸããã人ãçæ£ïŒããããïŒããŠããã®ãèŠããŸãããã®çæ£ã¯ãäŸãã°ãéåžžã«ç¹å®ã®åšæ³¢æ°ãæã£ãŠãããã©ã®çš®é¡ã®çæ£ã§ãåãã§ãããããã®çæ£ã¯ã人éã®é»ç£å Žã«ä¹±ããçããŠããããšã瀺ããŠããŸããã
ã¯ã¯ãã³ã«å«ãŸããã¢ã«ãããŠã ãLNPãã£ãã·ããPEGãå¯çè«ãªã©ã®ææ¯ç©è³ªã®äžã«é žåã°ã©ãã§ã³ãå«ãŸããŠããããšã¯ããããŒãã»ã€ã³ã°å士ã«ãã£ãŠããã«ç¢ºèªãããã66, 67  ããµã€ãšã³ãã£ã¹ãã»ã¯ã©ããããã¯ã¯ãã³ã«ããç²åãå«ãŸããŠããããšãé¡åŸ®é¡åçã§èšŒæããã¬ããŒããçºè¡šããŠããã
é»åé¡åŸ®é¡ãäœçžå·®é¡åŸ®é¡ãæèŠéé¡åŸ®é¡ãæèŠéé¡åŸ®é¡ãªã©ããã¡ããããããŒãã»ã€ã³ã°å士ãšåœŒã®ç§åŠããŒã ã«ãããªãªãžãã«ã®ç ç©¶çµæãããCoV-2-19ã¯ã¯ãã³ã«äœãå«ãŸããŠããã®ããæããã«ããã©ãã³ã¿ã»ã³ã«ã ãã®ç ç©¶è
ãçºèŠãããç£æ°æ¯æ§ãçŽ°èæ¯æ§ãéºäŒæ¯æ§ãæã€ææ¯ãªããéå±ã®å«æéããçåœãè
ããå¯çè«ã確èªãããããšã確èªããŸãããç©è³ªãšããŠã®é
žåã°ã©ãã§ã³ã«ã€ããŠã¯ãã¹ã¿ã³ãã©ãŒã倧åŠã®Hongjie Daiæ°ãã«ãã£ãŠ2008幎ã«çºèŠãããŠããŸããã 68
åçãªè¡æ¶²ã®å€å
<ç ç©¶ã§æããã«ãªã£ãè¡æ¶²ã®å€å>Â
ãããŒãã»ã€ã³ã°å士ã¯ãmRNAãæ³šå°ããåŸãã¯ã¯ãã³ãæ¥çš®ãã人ã®è¡æ¶²ãåçã«å€åããããšãçºèŠãããæ¬¡ã®ç»åã¯ãè²ã圢ã倧ãããåäžãªèµ€è¡çã®æ£åžžãªå¥åº·ç¶æ ã瀺ããŠããŸãã 6 9 AÂ

äœçžå·®é¡åŸ®é¡ã§æ®åœ±ãã2æç®ã®é¡åŸ®é¡åçã§ã¯ãmRNAã¯ã¯ãã³ãæ¥çš®ããŠãã24æéåŸã®çããè¡æ¶²ã«ããã€ã³ãå°äœãšåŒã°ããçµæ¶åããèµ€è¡çãçç©åŠçã«å€åããèµ€è¡çãšçœè¡çãäžå€®ã®ã°ã©ãã§ã³é žåç©çµæ¶ã®å€§ããªã·ã³ãã©ã¹ãããããŠé¡åŸ®é¡åçã®å³äžã«ãããªããã³é žã®çµæ¶ãåã£ãŠããŸãã
Page 20Â

ãã€ãã®ç ç©¶è ã¯ãã¯ã¯ãã³ãã€ã¢ã«ãçŽ30âïŒ85ºFïŒã«æž©ããã©ã³ãã®äžã«çœ®ããšãå 容ç©ãçµæ¶åããããšãçºèŠãããäžã®åçã¯ãã®æ§åãã¯ã£ãããšç€ºããŠããŸãã69BÂ

Page 21
æ°žä¹
ã«å
ã«æ»ããªãDNA
<人éã®ã²ãã ãæžãæãããã>Â
ãã£ãªãŒã»ãããŒãžå士ã¯ã20幎éã«ããã£ãŠã¯ã¯ãã³ãšãã©ã³ã¹ãã¥ãŒãããºã ãç ç©¶ããŠããŸãããã¹ãããã»ã¯ãŒã«ãã»ã³ã³ãããŒã«ãå¶äœããããã¥ã¡ã³ã¿ãªãŒãThe Battle For Humanityãã®äžã§ã圌女ã¯ããããã®æ³šå°ã人éã®DNAãæ°žä¹ ã«å€ããŠããŸããæ²æšãªçµæãæãå¯èœæ§ããããšèŠåããŠããŸããäžçäžã®ãã¡ã¯ããã§ãã«ãŒïŒã¯ã¯ãã³ç£æ¥ããå ±é ¬ãåŸãŠããããšãå€ãïŒã¯ãããããã§ã€ã¯ãã¥ãŒã¹ãšæ±ºãã€ããŸããããã§ã€ã¹ããã¯ã¯ããã®éºäŒåæ²»çã人éã®ã²ãã ãå€ããå¯èœæ§ãããããšãèŠåãã声ããã¹ãŠæ€é²ããæ¹éãæã¡åºããŸããããããããã§ã€ã¹ããã¯ã®åŸæ¥å¡ãããã§ã€ã¹ããã¯ã®CEOã§ããããŒã¯ã»ã¶ãã«ãŒããŒã°ãšã®ã€ã³ãµã€ããŒã»ãºãŒã ã»ããŒãã£ã³ã°ãèšé²ããå ¬éããŸãããåœŒã®æ£ç¢ºãªèšèã§ãã
ãæã ã¯ãåºæ¬çã«äººã®DNAãšRNAãæ¹å€ããŠãåºæ¬çã«ãããã®æäœãç£çããèœåãçŽæ¥ã³ãŒãåããããšã®é·æçãªå¯äœçšãšããããä»ã®çªç¶å€ç°ãäžæµã§ã®ä»ã®ãªã¹ã¯ãåŒãèµ·ãããã©ãããç¥ããªãã ãã§ãã ã63Â
ç¹èš±ãååŸãããã©ã³ã¹ãã¥ãŒãã³
<ãã¯ã人暩ãæã€äººéã§ã¯ãªãã®ã>Â
ã©ãã³ã¢ã¡ãªã«ã®å»åž«ã§ãããã³ãã»ãã©ã³ããªãŒãå士ã¯ãããã®ã²ãã ãæ¹å€ããããšããã®äººã¯æ¬æ¥ã®äººéã§ã¯ãªãããã©ã³ã¹ãã¥ãŒãã³ãšãªãã人暩ã倱ããšããäºå®ã蚎ããŠãããããã«ãæ¹å€ãããDNAãRNAã¯ç¹èš±ãšããŠèªããããéºäŒåæ¹å€ããã人éã¯ç¹èš±æš©è ã®ææç©ã«ãªããšèª¬æããŠããŸãããã®æå³ãããšããã¯ãéåžžã«ææ ®ãã¹ããã®ã§ããã64  Â
ãã©ã³ã¹ãã¥ãŒãã³ã»ãã€ããŒ
<çã£é»ãªç®ãšèåã®ä¿é²>
åç±³ã®ç§åŠè
ãå¥åŠãªçŸè±¡ã調æ»ããŠãããã¡ãã·ã³ã§ã¯ã¯ãã³ãæ¥çš®ãã䞡芪ããçãŸããæ°çå
ã®äžã«ã¯ãéåžžã®æ°çå
ã®ç®ã¯éåžžã«èãè²ãããŠããã®ã«ãç®ãçã£é»ã«ãªã£ãŠããåãããã®ã ããŸããçåŸ3ã«æã§ç«ã£ããæ©ãããã§ããããã«ãªããªã©ãèåãæ©ãŸã£ãŠããããã§ãã63A
Page 22
ãããã®èµ€ã¡ããã¯ãéºäŒåæ²»çã«ãã£ãŠDNAãå€ãããã䞡芪ããçãŸãããã©ã³ã¹ãã¥ãŒãããºã ã®äŸãªã®ã ãããïŒç ç©¶è
ãã¡ã¯ãæ©åç¹ããªãããã«æ°ãã€ããŠããŸãããä»åŸãããã«èª¿æ»ãé²ããŠããäºå®ã§ãã 63B  ãä»åŸãæ¬ã¬ããŒãã§ã¯ããã®çŸè±¡ã«ã€ããŠã®é²å±ããäŒãããŠãããŸãã äžã®åçã¯ãçãŸããã°ããã®èµ€ã¡ããã§ãç®ã®åšããæ·±ãé»ããªã£ãŠããŸããç³ã®äžã®çœãéšåãçã£é»ã§ãã

æäžéã®éã
<ãªãæ»ã¬äººãããã°ãå
æ°ãªäººãããã®ãïŒ>
äºé²æ¥çš®ãåããåŸãããäººã¯æ»ãã§ããŸã£ãããäžç身äœé害è ã«ãªã£ãŠããŸã£ããããã®ã«ããã人ã¯å æ°ã«èŠããã®ã¯ãªãã§ããããïŒ68B  ClinicalTrials.govã«ãããšãã¯ã¯ãã³æ¥çš®ã®å®éšã«ã¯æ§ã ãªæ®µéããããç°ãªãçšéã®mRNAãç°ãªãäººã«æäžãããŠããŸãã68BÂ
ã€ãŸããç¡å®³ãªç©è³ªã泚å°ããã人ãããã°ã5ã10ã20ã30ãã€ã¯ãã°ã©ã ã®mRNAãæ³šå°ããã人ããããšããããšã§ãã
ã«ããŒå士ã«ããã°ãããŒã¹ã¿ãŒã»ã·ã§ããã®äžã«ã¯100ãããã¯250ãã€ã¯ãã°ã©ã ãã®mRNAãå«ãŸããŠãããã€ã¢ã«ããããšãããããã§ãããå°åã§ã¯ã¯ã¯ãã³ãæ¥çš®ãã人ãå
æ°ããã«ããŠããã®ã«ãå¥ã®å°åã§ã¯ã¯ã¯ãã³ãæ¥çš®ããäººãæ»ãã§ããŸãã®ã説æãã€ãããŸãã§ãã·ã¢ã³ã«ãŒã¬ããã®ããã«ã誰ãèªåã®äœã«äœã泚å
¥ãããŠããã®ãç¥ããªãã®ã§ããã€ã³ãã©ãŒã ãã»ã³ã³ã»ã³ãããããŸããããããããã人ã
ãããŒã¹ã¿ãŒãåãããšããŠãããã®éã¯ç°ãªããŸãããããŸã§ã®æ³šå°ãç¡å®³ã ã£ããšããŠããæ¬¡ã®æ³šå°ã¯èŽåœçãªãã®ã«ãªããããããªãã®ã§ãã
Page 23
ã³ãããã«ããæ»äº¡è
æ°ã®äžæ£æäœ
<äžççãªè©æ¬ºã«ããã³ãããã®æ»äº¡è
æ°ã®å¢å >
äœçŸäžäººãã®äººã ããã®ãããªæ³šå°ã§æ®ºå®³ããå£å®ã¯ãã³ãããã«ããæ»äº¡ãé²ãããã ãšèšãããŠããŸããããããå®éã«ã¯ãããããã³ãããã®æ»äº¡è æ°ã¯ãæŽå²äžæå€§ã®åã§ãããäžçäžã§ãã³ãããã«ããæ»äº¡è ã®95ïŒ ä»¥äžãä»ã®åå ã«ããæ»äº¡è ã§ããããšãæããã«ãªã£ãŠããŸããã€ã¿ãªã¢ã®æ¿æ²»å®¶ãŽã£ãããªãªã»ã¹ã¬ãŒãã¯ãã€ã¿ãªã¢äžé¢ã§ããå«ãã ã69
ããããåã®äŒè°æã«ããªãããã«ããããåã¯ãããŸãããæ¬åœã®ããšãèšããŸãããã25,000äººã®æ»è ããããšã¯èšããªãã§ãããæ»è ãã¬ããªãã¯ããããªãºã ã«å©çšããŠã¯ãããªããé«çè¡çç ç©¶æã®æ°åã§ã¯ã96.3ïŒ ãä»ã®ç æ°ã§äº¡ããªã£ãŠãããã
ãã«ã®ãŒã®éèªãDe Tijdãã«ãããšãæ¿åºã¯3,000人ã®é«éœ¢è ãã³ããã19ã§æ»äº¡ãããšçºè¡šããåœäžãèŠææ å¢ã«å ¥ã£ãããããã調æ»ããŠã¿ããšã亡ããªã£ã人ã®3ïŒ ããæ€æ»ãåããŠããªãã£ãã3,000人ã§ã¯ãªãããã£ã90人ãã³ãããã«ææããŠããå¯èœæ§ãããã®ã ã 70
ã³ãããã«ããæ»äº¡è
æ°ãæ¥å¢ããäžæ¹ã§ãããã€ãã®åœã®çµ±èšã§ã¯ãçªç¶ãã€ã³ãã«ãšã³ã¶ã«ããæ»äº¡è
æ°ããŒãã«ãªã£ããã¢ã¡ãªã«ã ãã§ãæ¯å¹Ž4000äžäººè¿ãã®ã€ã³ãã«ãšã³ã¶æ£è
ãçºçããŠããããã³ãããã®ç»å Žä»¥æ¥ããã®æ°ã¯2000人以äžã«ãŸã§æžå°ãããšãããæ°åäžäººã®ã€ã³ãã«ãšã³ã¶æ£è
ã¯ã©ããžè¡ã£ãã®ãïŒä»ã§ã¯å
šå¡ãã³ããããšããŠç»é²ãããŠããŸãã

Page 24
ãã€ãã®æ³å»åŠè
ã§ããã¯ã©ãŠã¹ã»ãã¥ãã·ã§ã«ææã¯ããã³ãããã¯ãå§ãŸã£ãé ããã³ãã«ã°ã§140件以äžã®æ»äœã調æ»ããŸããããã€ãã®ãã¬ãçªçµã§ã圌ã¯ã³ãããŠã€ã«ã¹ã«é¢ãããã¹ããªãŒã¯éåžžã«èªåŒµããããã®ã§ãããšè¿°ã¹ãããã¥ãŒã·ã§ã«æ°ã«ããã°ãæ»äº¡ãã人ã
ã¯ãã¹ãŠåºç€çŸæ£ãããããŠã€ã«ã¹ããã£ãŠããªããŠãããããã«ããŠãããã«æ»ãã§ããã ãããšã®ããšã§ãããã©ãŒãŠã€ã«ã¹ãã¯ååšããªããšä»ãå ããŠãããå¥åº·ãªäººã¯å¿é
ããå¿
èŠã¯ãªãããšãã¥ãŒã·ã§ã«æ°ã¯èšãããŸããæ€èŠå®ã¯ãã³ããã¯å¹Žéã®æ»äº¡çã«ããŒã¯ãããããããšããªãã ãããšäºæž¬ããŠãããããã®äºæž¬ã¯æ£ç¢ºã§ããããšãããã£ããã71
äžçäžã®å»çé¢ä¿è
ããäžåžãããã¹ãŠã®æ£è
ãã³ããããšå ±åããåå ãäœã§ãããã¹ãŠã®æ»ãã³ãããã®æ»ãšããŠç»é²ããããã«å§åãããããããšèšŒèšããŠãããã€ã³ã¿ãŒãããäžã§ã¯ããã³ããããšã¯é¢ä¿ãªãç
æ°ã§å»è
ãç
é¢ã«è¡ã£ããããªããšã³ãããæ£è
ãšããŠç»é²ãããŠããããšããæ€æ
šãã人ã
ã®èšŒèšãäœåä»¶ãå¯ããããŠããã72
ãªã©ã³ãã®Doctors for Truthã®åµèšè
ã§ãããšã«ã±ã»ãã»ã¯ã©ãŒã¯å士ã¯ãæ«ææ£è
ã®æžé¡ã®äžã«ããããã®äººã
ãã³ãããã®æ»äº¡è
ãšããŠç»é²ããããæ±ããç§å¯ã®ã¡ãã»ãŒãžãåãåã£ããšèšŒèšããŠããŸã73 ãããžã§ã¯ãã»ãŽã§ãªã¿ã¹ã¯ããã¥ãŒãšãŒã¯ã®è¬å屿°äººã«é»è©±ãããã誰ãããããæ£ãããªãããšãç¥ã£ãŠããã«ããããããããã¹ãŠã®æ»è
ãã³ããããšããŠç»é²ãããŠãããšèšŒèšããŠããŸãã74ã çŸåœ¹ã®å»åž«ã§ããããããœã¿å·ã®äžé¢è°å¡ã¹ã³ããã»ãžã§ã³ã»ã³æ°ã¯ããã©ãã¯ã¹ã»ãã¥ãŒã¹ã§ãç±³åœã®ç
é¢ãæ£è
ãã³ããããšããŠç»é²ããããšã«è«å€§ãªééçã€ã³ã»ã³ãã£ããåããŠããããšãæããã«ããŸããã75 ãCNNã®ãã¯ãã«ã«ã»ãã£ã¬ã¯ã¿ãŒããã£ãŒãªãŒã»ãã§ã¹ã¿ãŒã¯ãããžã§ã¯ãã»ãŽã§ãªã¿ã¹ã®èŠé¢ãžã£ãŒããªã¹ãã«ç§å¯è£ã«æ®åœ±ãããCNNãæ»äº¡çãèªåŒµããããšãèªãããã76
ã¢ããªã«ã®æ¿åºé¢ä¿è ãšã®ãºãŒã ã»ããŒãã£ã³ã°ã®æ§åããªãŒã¯ãããããã¯ããŠã³ãç¶ããããã«ã³ãããã®æ°ãå¢ããæ¹æ³ã話ãåã£ãŠããããšãæããã«ãªã£ãã 77
National File瀟ã¯ãããŒã¹ã«ãã©ã€ãå·ãšãµãŠã¹ã«ãã©ã€ãå·ã§æ£è
ãæ²»çãã20ã®ç
é¢ã蚺çæããªãã£ã¹ãããªãNovant Heath New Hanover Regional Medical Centerã®å»åž«ãšããŒã±ãã£ã³ã°ã»ãã£ã¬ã¯ã¿ãŒãšã®éã§è¡ããããºãŒã äŒè°ã®é²é³ãå
¬éããŸããããã®é²é³ã®äžã§ãã¡ã¢ãªãŒã»ã«ãã£ãã¯å»åŠå士ã¯ãããŒã±ãã£ã³ã°ãã£ã¬ã¯ã¿ãŒã®ãã£ããªã³ã»ãã£ãã·ã£ãŒãšä»ã®ç
é¢è·å¡ã«ãCOVID-19ã®æ£è
æ°ããããšå¢å ããããããäºé²æ¥çš®ãåããªããã°æ»ã¬ããšãããã£ãŠããããšèª€èªããããããªã¡ãã»ãŒãžã䜿ã£ããããããšã§ãç
é¢ããã£ãšãäžè¬ã®äººã«ãšã£ãŠæãååšãã«ãªã£ãŠã»ãããšèªã£ãŠããŸãã78
ãã¥ãŒãšãŒã¯ã¯COVID-19ãã³ãããã¯ã®éæºå°ã§ããããã¥ãŒãšãŒã¯ã®äžå¿éšã«ã¯æåãªãšã«ã ããŒã¹ãç
é¢ããããããã§äžçã§æãå€ãã®äººããã®ãŠã€ã«ã¹ã§äº¡ããªã£ããšèšãããŠããŸãããã³ãããã¯ã®éæºå°äžã®éæºå°ã ã£ãã®ã ããã®ããããããªãããæ¥ãçµéšè±å¯ãªçè·åž«ããšãªã³ã»ãªã«ãŒãã¹ãã¯ã屿©ç®¡çã®ããã«çŸå°ã«èµŽãããšã«ããŸããã
Page 25
ããããäžççã«æåãªãã®ç é¢ã§ç®ã«ãããã®ã¯ãããŸãã«ãæããããã®ã ã£ãã®ã§ã圌女ã¯é ãã«ã¡ã©ãæã£ãŠãã®æ§åãæ®åœ±ããããšã«ããŸããã
COVID-19ã®æ€æ»ã§äœåºŠãé°æ§ã«ãªã£ãæ£è ã§ããCOVID-19確å®ããšããŠç»é²ãããã圌ãã¯ã³ãŽã£ããç æ£ã§åŒåžåšãè£ çãããæ»ã«è³ãã®ã§ãã
Journeyman Picturesã«ããããã¥ã¡ã³ã¿ãªãŒã§ã¯ããã®çè·åž«ãããšã«ã ããŒã¹ãã§åžžã«èµ·ããŠããç¯çœªã«ã€ããŠèªã£ãŠããŸãã圌女ã¯ãããæ£è ãå®éã«COVID-19ã®æ€æ»ã2ååããŠé°æ§ã ã£ãã«ããããããããCOVID-19ã確èªãããããšç»é²ãããæ§åãã¹ããŒããã©ã³ã§èŠããŠããŸãã圌女ã¯ããã®ãããªããšããšã«ã ããŒã¹ãã§ã¯åžžã«èµ·ãã£ãŠãããšèª¬æããŠããŸããã€ãŸããéšãèšã¡ã殺人ãè¡ãããçµæãCOVID-19ã«ããæ»äº¡çãé«ããªããã¡ãã£ã¢ã§å€§ã çã«å ±éãããŠããã®ã§ãã 79
è¬åå±ã¯èªã
<æ¿åºã®ç¯çœªãç®æããè¬åå±>Â
è¬åå±ã®John O'Looneyæ°ã¯ã10幎éãè±åœæå€§çŽã®è¬åäŒç€Ÿã«æå±ããBBCãšååããŠãã³ãããã¯ã®æ§åãèšé²ããæ¿åºã®ãã³ãããã¯æ
åœè
ãšä»äºãããã圌ã¯ä»ã®45瀟ã®è¬åå±ãšã€ãªãã£ãŠããã®ã§ãäœãèµ·ãã£ãŠããã®ããæç¢ºã«ææ¡ããŠããã圌ãæããå
容ã¯è¡æçã§ãããŸãã圌ã¯ããããããã³ãããã¯ã®éãèªåãä»ã®è¬åå±ãæ»äº¡è
ã®å¢å ãèŠãŠããªããšèšŒèšããããããã2020幎3æããžã§ã³ã¯çªç¶ã3é±éã«ããã£ãŠå€ãªå€ãªä»è·æœèšã«åŒã³åºãããŸããã亡ããªã£ãæ¹ã¯å
šå¡ãã³ããããšæžãããŠããŸããã圌ã¯äžåºŠãå»åž«ã®ç«ã¡äŒããèŠãããšããªããã³ãããã®æ€æ»ãããããšããªãã£ãããããšåæã«ããããŸã©ã ã®è³Œå
¥éã1,000%å¢å ããŸãããããçè·åž«ã«ãããšãé«éœ¢è
ã倧éã«é§é€ããããã«ããã®è¬ã®èŽæ»éãæäžããããã«æç€ºãããŠããããã§ãããã®ãããªå€§éã®æ»è
ãåºãããšã§ããã³ãããã®ãã³ãããã¯ããšããã¹ããŒãªãŒãå±éãããã®ã§ãã
ãŸããåœŒã¯æ¿åºã®ãã³ãããã¯æ
åœè
ããããæ»å ãã³ããããšè¡šç€ºããªããã°ãªããªãããšèšãããŠãããè»ã«èœ¢ããã人ãå¿èçºäœãã¬ã³æ£è
ãªã©ãäœãåå ã§æ»ãã ãã¯é¢ä¿ãªãããã¹ãŠã³ãããã®æ»ãšè¡šç€ºããªããã°ãªããªãã®ã ã
ãã£ãããæ¿åºãã€ã®ãªã¹åœæ°ã«å€§éã®ã¯ã¯ãã³ãæ¥çš®ãå§ãããšããžã§ã³ããã«ãããšãæ»äº¡è
æ°ã¯æ¥å¢ããããã§ããè¬åå±ã15幎ãã£ãŠãããããããªããšã¯åããŠã ããŸãã«è
ã«éãåºãããã«ãªã£ãŠããå§ãŸã£ãã®ã§ãããã®ãããªæ»äº¡çã¯äºåºŠãšèŠãããšããããŸããã
Page 26
ãæããããæãããã§ãããããã¯ãã³ãããã¯ã®æ°åã§ãããããã¯ã¯ã¯ãã³æ¥çš®ãå§ãŸã£ãŠããã®ããšã§ããã以åã«ãã®æ§ãªæ»è
æ°ã¯ãããŸããã§ããããžã§ã³ããã®èª¬æã«ãããšãã¯ã¯ãã³ã«ããæ»äº¡è
ã®ã»ãšãã©ã¯ãã³ãããã»æ»ããšåŒã°ããŠããããã§ãããèª å®ãã®ãããããªãè¬åå±ããã¯ã¿ããªãç§ãã¡ã®åšãã§æ»ãã§ãã人ãã¡ã¯ã¿ããªã¯ã¯ãã³ãåãã人ãã¡ã ãšèšãã§ããããã³ãããã®ãã³ãããã¯ã¯ååšããªãããç§ããã®çãã蚌æ ã ããã¹ãŠã¯ã¯ã¯ãã³ãåããããããã«äœãããŠããã®ã§ããç§ã®è¬åå±ã®ãããã¯ãŒã¯ã§ã¯ãã³ãããã§æ»ãã åäŸã¯äžäººãããŸãããã§ãããããã®ãããªéºäŒåæ²»çãåäŸã«æœãçç±ã¯å
šããããŸããã ããã«ã¯éçåã®æå³ããããŸãã人ã
ãæ®ºããŠããã®ã¯ã¯ã¯ãã³ãªã®ã§ããç§ã¯è¬åå±ãšããŠãã®ããšãç®ã®åœããã«ããŠããŸããã
äžççãªäžæ£è¡çº
å»çåŸäºè
ã¯ããã¹ãŠã®æ£è
ãã³ããããšããŠç»é²ããããå ±é
¬ãåŸãŠããŸããæ¯å¹Žãäœå人ãã®ã€ã³ãã«ãšã³ã¶æ£è
ãããã¹ãŠã³ãããã«ãªã£ãŠããã®ã§ããå»åž«ã¯ãçæ»ã®æ£è
ãã³ãããã«ããæ»äº¡ãšããŠç»é²ããããæ±ããã¡ãã»ãŒãžãé ããŠåãåã£ãŠãããè¬åå±ã¯åœã®ã³ãããç»é²ãåžžã«èŠãŠããããšãèªããCNNã®ãã¯ãã«ã«ã»ãã£ã¬ã¯ã¿ãŒã§ãããã§ã¹ã¿ãŒã¯ã³ãããã®æ°ãå¢ãããŠããããšãåçœããã20ã®ç
é¢ãããªããããã¯ãŒã¯ã§ã¯ãææå¿ãç
œãããã«ã³ãããã®æ°ãå¢ãããŠãããã¢ããªã«ã®æ¿åºé¢ä¿è
ãã³ãããã®æ°ãå¢ããæ¹æ³ã話ãåã£ãŠããæ§åããºãŒã ã³ãŒã«ã«æ ã£ãŠãããã³ãããã®æ»äº¡è
æ°ãå¢ããããã«ã倧éã®æ£è
ãæ®ºå®³ãããããšãçè·åž«ã蚌èšããäžçäžã®ç¡æ°ã®äººã
ãã³ããããšããŠèª€ã£ãŠç»é²ãããããšã«æ€æ
šããŸãã ã€ã¿ãªã¢ã®æ¿æ²»å®¶ããããªãªã¯ãäŒè°å®€ãããã«åãã€ããŠããããç¥ããæ¿æããããããŠãããè¬åå±ã¯ãã³ãŽã£ãããšåŒã°ããæ»ãäœãåºãããã«ãäœå人ãã®èäººãæ®ºå®³ãããã®ãç®æããã圌ãã¯ãããšããå€ãã®è¬åå±ã¯ãè±åœæ¿åºãããã¹ãŠã®æ»ãã³ããããšåŒã¶ããã«æç€ºãããŠãããäºé²æ¥çš®ãå§ãŸããšã圌ãã¯çãåäŸã®ãªãççºçãªæ»ãç®ã®åœããã«ããã
Page 27
ã¯ã¯ãã³ãåãã人ã ããæ»äº¡
<ã¹ãã€ã³é¢šéªã§ã¯ã¯ã¯ãã³ãåããäººãæ»äº¡ãã>Â
1918幎ããã¹ãã€ã³é¢šéªããšåŒã°ããç æ°ã§ã5,000äžäººãã1å人ãšããæ²æšãªæ°ã®äººã ã亡ããªã£ããšèšãããŠããŸãããã®åºæ¥äºãç®ã®åœããã«ããå°éå®¶ã¯ãå»åŠè ã®ãšã¬ãã¢ã»ãã¯ããŒã³å士ïŒN.D.ïŒã§ã圌女ã¯äœãèµ·ãã£ãŠããã®ããçŽæ¥äœéšããŠæ¬ã«æžããŠããŸãã81,ã82ã圌女ã¯ãã€ã³ãã«ãšã³ã¶ã§ã¯ãªãã倧éã®äºé²æ¥çš®ãåœæ°ã«èª²ããããããã«ãã€ã³ãã«ãšã³ã¶ã®ãããªçç¶ãããŸããŸãªç æ°ãçºçãã倿°ã®æ»è ãåºããšèª¬æããã
圌女ã¯ããã®çæã®ãã¹ãã€ã³é¢šéªãã§æ»äº¡ããã¯ã¯ãã³æªæ¥çš®è ãäžäººãç¥ãããäžæ¹ã§ã¯ã¯ãã³æ¥çš®è ã®å€ãã¯åœãèœãšããŠããã
ãç§ã¯1918幎ã®ã€ã³ãã«ãšã³ã¶ã®æµè¡ãçŸå Žã§èгå¯ããŠããŸããã1918幎ã®ã¹ãã€ã³é¢šéªã®æµè¡æã«çããŠããå»åž«ã人ã ã¯çãäžçãçµéšããããšã®ãªãæãããç æ°ã ã£ããšèšã£ãŠãããäžå€«ãªç·ããããæ¥çªç¶ãæ»ãã§ããŸãã®ã ãè žããã¹ããžãããªã¢ãèºçã倩ç¶çã麻çºãªã©ãç¬¬äžæ¬¡äžç倧æŠçŽåŸã«äººã ãäºé²æ¥çš®ãåããç æ°ã«ã黿»ç ã®ç¹åŸŽãå ãã£ããã®ã ã£ããå®è³ªçã«å šåœæ°ã12çš®é¡ä»¥äžã®ç æ°ãæ¯ç©ã®è¡æž ããçš®ããšããŠæ³šå°ãããŠããã®ã§ããããã®å»åž«ãäœã£ãç æ°ãäžæã«çºçãããšãã¯ãæ²æšãªããšã«ãªã£ããçç¶ãæããããšããå»åž«ãã¡ããããã«æ¯è¬ã远å ããŠã2幎éããã³ãããã¯ãç¶ããã
ç§ã調ã¹ãéãã§ã¯ãã€ã³ãã«ãšã³ã¶ã¯äºé²æ¥çš®ãåãã人ã ãã眹æ£ããŸãããäºé²æ¥çš®ãæåŠããŠãã人ãã¡ã¯ã€ã³ãã«ãšã³ã¶ããéããŸããã
ç§ã®å®¶æã¯ãã¹ãŠã®äºé²æ¥çš®ãæåŠããŠããã®ã§ããã€ãå
æ°ã ã£ããã°ã©ãã ããã¬ã€ã«ããã£ã«ãã³ãªã©ã®å¥åº·ã®æããããäººã¯æ¯ç©ã§äœãæ±ããŠãç
æ°ã«ãªããªãããšãç¥ã£ãŠããããã ãã€ã³ãã«ãšã³ã¶ãæµè¡ããŠããé ã¯ãåºã¯ãã¡ãããåŠæ ¡ãäŒç€Ÿãããã«ã¯ç
é¢ãŸã§ããééãããŠããŸããããå»åž«ãçè·åž«ãäºé²æ¥çš®ãåããŠãããããã€ã³ãã«ãšã³ã¶ã«ããã£ãŠããŸãããè¡ã«ã¯èª°ãããŸããã§ããããŸãã§ãŽãŒã¹ãã¿ãŠã³ã®ããã ã£ããç§ãã¡ïŒã¯ã¯ãã³ãæããªãã£ãïŒã¯ãã€ã³ãã«ãšã³ã¶ã«ããããªãã£ãå¯äžã®å®¶æã®ããã§ãããç§ã®äž¡èŠªã¯ãå®¶ããå®¶ãžãšç§»åããã§ããéãç
人ã®äžè©±ãããŸããããåœæã¯å»è
ã«ãããããšã¯äžå¯èœã§ãããããã现èããã¯ããªã¢ããŠã€ã«ã¹ãããã«ã¹ãªã©ãç
æ°ãåŒãèµ·ããå¯èœæ§ããããšããã°ãç
宀ã§äœæéãéãããŠããäž¡èŠªãæ»æããæ©äŒã¯ãããã§ããã£ãã¯ãã§ãããããã圌ãã¯ã€ã³ãã«ãšã³ã¶ã«ã¯ããããã现èãå®¶ã«æã¡åž°ã£ãŠç§ãã¡åäŸãæ»æããããäœããåŒãèµ·ããããããããšããããŸããã§ãããç§ãã¡ã®å®¶æã¯èª°ãã€ã³ãã«ãšã³ã¶ã«ããããã錻氎ãåºãŸããã§ããããéªãæ·±ãç©ãã£ãå¬ã®ããšã§ããã
Page 28
1918å¹Žã«æµè¡ããã€ã³ãã«ãšã³ã¶ã§ã¯ãäžçäžã§2,000äžäººãæ»äº¡ãããšèšãããŠããŸããããããå»è
ã¯ç²æªã§èŽåœçãªæ²»çæ³ãè¬ã§åœŒããæ®ºããã®ã§ãããããã¯å³ããåçºã§ããããæ²»çã«åœãã£ãå»åž«éã®æåã«æ¯ã¹ãŠè¬ã䜿ããªãã£ãå»åž«ããæåããããšãã倿ãããšãäºå®ãªã®ã§ããã
å»çé¢ä¿è
ãç
é¢ã§ã¯ãã€ã³ãã«ãšã³ã¶ã«ããã£ãæ£è
ã®33ïŒ
ã亡ããªã£ãŠããããããã«ã¯ãªãŒã¯ãã±ããã°ããã¯ãã¡ãã³ã®å¥åº·å埩ã»ã³ã¿ãŒãªã©ã®éå»çç
é¢ã§ã¯ãæ°Žæ²»çãå
¥æµŽãæµ£è
žãªã©ã®æ¹æ³ããæé£ãªã©ã®ç°¡åãªæ²»çæ³ãããã«èªç¶é£åã䜿ã£ãäžå¯§ãªé£äºã§ãã»ãŒ100ïŒ
ã®æ²»çãåŸãããŠããã®ã§ãããããä¿å¥å»ã¯8幎éãæ£è
ãäžäººã倱ã£ãŠããªããšãããè¬ã䜿ããã«æ£è
ã倱ããªãã£ãããå»åž«ã®éåžžã«æåããå¥åº·æ³ã«ã€ããŠã¯ãå°ãåŸã«åºçããããVACCINATION CONDEMNEDããšé¡ããããã®æ¬ã®å¥ã®éšåã§ç޹ä»ãããŸããããããå»åŠè
ãç¡è¬ã®å»è
ãšåãããã鲿©ããŠããããå»åŠçãªã€ã³ãã«ãšã³ã¶æ²»çã«ãã2000äžäººã®æ»ã¯ãªãã£ãã§ãããã
ã¯ã¯ãã³ãåããå
µå£«ã®ç
æ°ã¯ãã¯ã¯ãã³ãåããŠããªãäžè¬åžæ°ã®7åãããããã®ç
æ°ã¯ã¯ã¯ãã³ãåãããã®ã§ãã£ãã1912å¹Žã«æµ·å€ããåž°åœããããå
µå£«ã¯ãéžè»ç
é¢ã«ã¯å°å
麻çºã®æ£è
ãããããããŠããªã倧人ã®ç·æ§ã幌å
ã®ç
æ°ã«ãããã®ããšäžæè°ã«æã£ãŠãããšèšã£ãŠããŸãããä»ã§ã¯ã麻çºã¯ã¯ã¯ãã³äžæ¯ã®äžè¬çãªåŸéºçã§ããããšãåãã£ãŠãããåœå
ã®äººã
ã麻çºã«ãªã£ãã®ã¯ã1918幎ã«äžççãªã¯ã¯ãã³æ¥çš®ãã£ã³ããŒã³ãè¡ãããåŸã®ããšã§ãããã
ãäºé²æ¥çš®ãåããåŸã7人ã®ç·æ§ãå»åž«ã®èšºå¯å®€ã§æ»äº¡ããã圌ãã®å®¶æã«ã¯è»äºè¡åã§æ»äº¡ãããšããæçŽãéãããããÂ
ãšã¬ãã¢ã»ãã¯ããŒã³å士 N.D.
圌女ã®å°éçãªå»åŠèŠå°ããã®ç®æè
ãšããŠã®èšŒèšã¯ãåŸã«æ€æ»ã«ãã£ãŠç¢ºèªãããå®éã«ã¯ã€ã³ãã«ãšã³ã¶ã§ã¯ãªããå®éšçãªãçŽ°èæ§é«èçã¯ã¯ãã³ãã®ç¡äœçºãªæäžã«ãã£ãŠåŒãèµ·ããããèŠãã¿ã§ãã£ãããšã倿ãããå
µå£«ãæ°é人ã®å
ç«ã·ã¹ãã ãæºåãããŠããªãç¶æ
ã§ã远å ã®ã¯ã¯ãã³ã倧éã«äœåºŠãæ¥çš®ããããšã§ããæ®ºæ®ã®å Žããäœãåºããã®ã§ããã¯ã¯ãã³ãæ¥çš®ããŠããªã人ã¯åœ±é¿ãåããŸããã§ããã
Page 29
解決çïŒæ©ææ²»ç
<第äžç·ã®ç§åŠè
éãçããåºãã>Â
æå®³ãªã³ãããã®æ³šå°ãCOVID-19ç ã®è§£æ±ºçã«ãªããªããšããããã©ããã£ãŠäººé¡ãå©ããããšãã§ããã§ããããïŒ çãã¯ç°¡åã§ãããã®äžççãªå¥åº·å±æ©ãå§ãŸã£ãåœåãããå€ãã®èåãªç§åŠè ãå»åž«ããå®å šæ§ãšæå¹æ§ã§ç¥ãããæ¢åã®è¬ã䜿ã£ãŠãäœå人ãã®ã³ãããæ£è ã®æ²»çã«æåããŠããããšãå ¬èšããŠããŸãããäŸãã°ãäžççã«æåãªãã©ã³ã¹ã®ãã£ãã£ãšã»ã©ãŠãŒã«ææã¯ãææçãšåŸ®çç©åŠã«ãããæå€§ã®ç ç©¶ã°ã«ãŒãã®ãã£ã¬ã¯ã¿ãŒã§ããã埮çç©åŠã®åéã§æãåŒçšãããŠãã人ç©ã§ããISIã«ãããšããšãŒãããã§æãåŒçšãããŠãã埮çç©åŠè ã§ããã1998幎以éã457人以äžã®å€åœäººç§åŠè ãç ç©¶å®€ã§æè²ããISIãPubmedã§1950以äžã®è«æãåç §ãããŠãããææçã®äžççãªç¬¬äžäººè ãšãããŠããŸããã©ãŠãŒã«ææã¯ã60幎以äžã®æŽå²ããããã³ãããŠã€ã«ã¹ã«å¯Ÿããå®å šæ§ãšå¹çæ§ã§æåãªè¬ãããããã·ã¯ãããã³ãçšããŠã³ãããæ£è ã®æ²»çãéå§ããŸããã
ã©ãŠãŒã«ææã¯4,000人以äžã®æ£è ãããããã·ã¯ãããã³ãšã¢ãžã¹ããã€ã·ã³ã§æ²»çãããã§ã«ããã€ãã®ç çç¶æ ã«ãã£ãäžæ¡ãã®è¶ é«éœ¢è ãé€ããŠãäºå®äžãã¹ãŠã®æ£è ãå埩ããã83
ãã®é©ãã¹ãæåã«è§ŠçºãããŠãäžçäžã®å€ãã®å»åž«ãåãè¬ã䜿ãå§ããŸããããªã©ã³ãã®ããã»ãšã¬ã³ã¹å士ã¯ãã³ãããã®æ£è å šå¡ã«ããããã·ã¯ãããã³ïŒHCQïŒãšäºéïŒZnïŒã䜵çšããŠæäžãããšãããå¹³å4æ¥ã§100ïŒ ã®å埩çã瀺ããŸããã誰ãå ¥é¢ããå¿ èŠã¯ãããŸããã§ããããã®å»åž«ã¯ã2,700人以äžã®ä»ã®å»çé¢ä¿è ãšãšãã«ããªã©ã³ãæ¿åºã«æçŽãéããHCQãæšæºãããã³ã«ã«å ããããã«èŠè«ããããšã¬ã³ã¹å士ãšä»ã®ãªã©ã³ã人å»åž«ã¯ããCOVID-19ã»ã«ãã±ã¢ãã®ãŠã§ããµã€ããç«ã¡äžããHCQãšäºéã䜿ã£ãCOVID-19ã®äºé²ãšå æã®æ¹æ³ã«ã€ããŠã®æ å ±ãæ²èŒããã84
ãã¥ãŒãšãŒã¯ã§ã¯ãå®¶åºå»ã®DR. Vladimir Zelenko(ãŠã©ãžããŒã«ã»ãŒã¬ã³ã³ïŒå士ãããã³ãããã¯ã®åæã«500人以äžã®ã³ãããæ£è
ãããããã·ã¯ãããã³ïŒäºéïŒã¢ãžã¹ããã€ã·ã³ã§æ²»çããŸããããŸããå¯äœçšãã»ãšãã©ãªããå
¥é¢ããªãã100ïŒ
ã®å埩çãèšé²ããŸããã85ã2021幎8æçŸåšããŒã¬ã³ã³å士ãšãã®ããŒã ã¯ã6,000人以äžã®ã³ãããæ£è
ã®æ²»çã«æåããŠããŸãã圌ãéçºããCOVID-19ãæ²»çãããããã³ã«ã¯äžççã«æåã«ãªããäžçäžã®äœçŸäžãäœå人ãã®äººã
ã®åœãæã£ãŠããŸãããŒã¬ã³ã³ã»ãããã³ã«ã¯ããªã³ã©ã€ã³é éå»çãã©ãããã©ãŒã https://www.speakwithanmd.com/ ãã80äžäººä»¥äžã®ã¡ã³ããŒãããªãåºå€§ãªãããã¯ãŒã¯ãæã€America's Frontline Doctorsãªã©ã§äœ¿çšãããŠããŸãã 86
Page 30
äœçŸãã®ç ç©¶ã«ãããHCQ ã COVID - 19 ã®æ²»çãå ¥é¢ã»æ»äº¡ã®äºé²ã«æå¹ã§ããããšã確èªãããŠããŸãã 87 , 88 , 89
äžççãªç§åŠè ã§ããããšãŒã«ã»ã³ãŒãªãŒå士ãšããŒã¿ãŒã»ããã«ãå士ã¯ãããããã®åéã§æãå€ãã®è«æãçºè¡šããŠããå»åŠå°éå®¶ã§ãããããã®å»åž«ãšãã®ããŒã ã¯ãã€ãã«ã¡ã¯ãã³ãªã©ãçšããŠäœäžäººãã®ã³ãããæ£è ã®æ²»çã«æåããŠããŸããã³ãŒãªãŒå士ãšåœŒã®ããŒã ã¯ã9ã¶æä»¥äžã«ããã£ãŠãã¹ãŠã®å»åŠæç®ã調æ»ããã€ãã«ã¡ã¯ãã³ãCOVID-19ã广çã«äºé²ã»æ²»çãããã©ã¯ã«ã»ãã©ãã°ã§ããããšã蚌æããŸããã
ã€ãã«ã¡ã¯ãã³ãCOVID-19ã®æ²»çã«æå¹ã§ããããšã¯ã63ã®å°éå®¶ã«ããç ç©¶ã§ç¢ºèªãããŠããŸãã 90 , 91 , 92
çç©ç©çåŠè ã®ã¢ã³ãã¬ã¢ã¹ã»ã«ã«ã«ãŒïŒAndreas KalckerïŒã¯ãäºé žåå¡©çŽ ã䜿ã£ãŠãããªãã¢ã§1æ¥ã®æ»äº¡ç100人ã0人ã«ãŸã§æžãããã©ãã³ã¢ã¡ãªã«ã®ããã€ãã®åœã®è»ãèŠå¯ãæ¿æ²»å®¶ã®æ²»çãäŸé Œãããã圌ã®äžççãªãããã¯ãŒã¯ã§ããCOMUSAV.comã¯ããã®å¹æçãªæ²»çæ³ãæšé²ããŠããæ°å人ã®å»åž«ãåŠè ãç§åŠè ãåŒè·å£«ã§æ§æãããŠãã93 , 94 , 95ã
Covidã®æ©ææ²»çã«é¢ããæ å ±ã¯ã以äžã®ãŠã§ããµã€ãã«æ²èŒãããŠããŸãã
www.CovidPatientGuide.com
www.C19Protocols.com
www.TheCovidRemedy.com
www.FlemingMethod.com/best-available-published-evidence
www.StopWorldControl.com/cures
Page 31
æ²»çã®ãµããŒã
<äžçäžã®å»åž«ãã¡ã迫害ãããŠãã>Â
COVID-19ã®æ²»çã«ã¯ããã€ãã®éžæè¢ããããŸããããªãããŸã ã«ã¯ã¯ãã³ãæ±ãã声ã倧ããã®ã§ããããããŸãããªãåœæ°ã®å€§å€æ°ãæ²»çæ³ãç¥ããªãã®ã§ããããïŒãã®çãã¯è¡æçã§ããã®äžçã§äœãèµ·ãã£ãŠããã®ããæ¹ããŠç€ºããŠããŸãã
äžçäžã§ãã³ãããã®æ²»çã«æåããå»åž«ãã¡ã¯ãæ¿åºã«è
è¿«ãããééããããšããèããããªãäºæ
ã«ééããŸããã
ã¢ã¡ãªã«ã®ç¬¬äžç·ã§æŽ»èºããå»åž«ãã¡ã¯ã2020幎ã«éå¬ããã第1åãã¯ã€ãã³ãŒãã»ãµãããã§ãå®å šã§å¹æçãªã³ãããã®æ²»çæ³ãäžçã«çºä¿¡ããŸããããã®æŸéã¯æ°æéã§2000äžå以äžèŠèŽãããŸãããããã®åŸãå šé¢çã«ã·ã£ããããŠã³ãããŸãããFacebookãYoutubeãTwitterããããŠåœŒãã®ãŠã§ããµã€ããŸã§ããSquarespace瀟ã«ãã£ãŠééãããŠããŸããŸãããããªã¹ãã£ãã¯å»çã®ç¬¬äžäººè ã§ãããã·ã¬ã³å·ã®ããããã»ãã©ãŠã³ã¹ã¿ã€ã³å士ã¯ã120人以äžã®ã³ãŽã£ããæ£è ã®æ²»çã«æåããŠããŸãããã圌ã®å»çããã°ã¯ãã¹ãŠåé€ãããŠããŸããŸããããªã©ã³ãã§ãã¹ãŠã®ã³ãããæ£è ã®æ²»çã«æåããããã»ãšã¬ã³ãºå士ã¯ãæ¿åºããããã®ãŸãŸæ²»çãç¶ãããšå èš±ã倱ãããšè ãããŸãããå¥åº·çãªç掻ã«é¢ããäžççãªçºèšè ã§ãããžã§ã»ãã»ããŒã³ã©å士ã¯ãã³ãããã®æ²»çæ³ã«é¢ããæ å ±ãå ¬éããŠããŸããããGoogleãããã§ã«çŠæ¢ãããŠãããããã³ã³ãã³ãã®åé€ãäœåãªããããŸãããäžçã§æãå°æ¬ãããŠããç§åŠè ã®äžäººã§ããRaoultææã¯ãçªç¶ã€ã³ã¿ãŒãããäžã§èª¹è¬äžå·ãããŸãã6,000人以äžã®æ£è ã®æ²»çã«æåãããã®äžã«ã¯2人ã®å€§çµ±é ãã€ã¹ã©ãšã«ã®ä¿å¥å€§è£ãå«ãŸããŠãããŒã¬ã³ã³å士ãããããäžã§éé£ãããåçºã®ããã«èªåã®ã³ãã¥ããã£ãé¢ããããåŸãªããªããŸããã
çç©ç©çåŠè ã®ã¢ã³ãã¬ã¢ã¹ã»ã«ã«ã«ãŒã¯ããã¹ãŠã®äž»èŠã¡ãã£ã¢ããæé€ãããèæžã¯ã¢ããŸã³ããåé€ãããResearchGateã®ç§åŠè ã¢ã«ãŠã³ããåé€ãããŸããã
ãããã¯ãã³ãããã®æ²»çã«æåããå»åž«ãç§åŠè
ãå€§èŠæš¡ãªå察ã«éã£ãäŸã®ã»ãã®äžéšã«éããŸããã人é¡ã®æŽå²ã®äžã§ãããç
æ°ã«å¹ãå®å
šãªè¬ããããã»ã©ãŸã§ã«åœéçã«å調ããŠäžçããé ãããããããšã¯ãããŸãããäžçã®äººã
ããã®èŽæ»çãªæ³šå°ãåãå
¥ããããã«æããããå¿
èŠããããããã³ããããã人ã
ãå埩ããããšã¯æ³å®ãããŠããŸããã
ãã®ãããªå»åž«ã®æ€é²ã«é¢ãããã¹ãŠã®èšŒæ ã¯ããã¡ããã芧ãã ãã: StopWorldControl.com/full
Page 32
究極ã®ãã€ã³ãã³ã³ãããŒã«
<ããªã®å€§çµ±é ãçºè¡šããæ¥µæªééãªèšç»>Â
ãåç¥ã®ããã«ãç¯çœªè ã®ç®çã¯åžžã«èªåã®æš©åãšå¯ãå¢ããããšã§ãã圌ãã¯æ±ºããŠæºè¶³ããããšãªããåžžã«ããå€ãã®ãã®ãæ±ããŠããŸããæçµçã«ã¯ãå šäžçã§ãç¥ããæŒãã誰ãã圌ãã®ããã¹ã«ãªãããšãæãã§ããŸãã圌ããæš©åãæ¡å€§ãç¶ããããã«å¿ èŠãªãã®ã¯ã倧è¡ã®ç²ç®çãªåŸé ãã§ãã圌ãã®èšç»ã«ååããŠãããã®ã¯ããŸã£ããç¡ç¥ã§ããŸã£ããåŸé ãªäººã ã ãã ãã ããããã圌ãã¯äžçäžã®äž»èŠãªå ±éæ©é¢ãæè²ã·ã¹ãã ãå»çãæ¿åºæ©é¢ãªã©ãè²·åãããã®ãã¹ãŠã䜿ã£ãŠäžçäžã®ããããå¿ã«æŽè³ãããã¬ã³ããåºããããšããŠããã®ã ãããããããã§çµããã§ã¯ãããŸããã圌ãã¯ã誰ãããã¬ãã®æ å ±ããã¹ãŠä¿¡ããããã§ã¯ãªãããšãååã«çè§£ããŠããŸãããã®ãããå šäººé¡ã®å¿ã100ïŒ ã³ã³ãããŒã«ãããšãã圌ãã®èšç»ã¯ããã«çºå±ããŠãããæè¿ã§ã¯ãããªã®ã»ãã¹ãã£ã¢ã³ã»ããã§ã©å€§çµ±é ãã圌ãã®èšç»ãã¯ã£ãããšè¡šæããŸããã圌ã¯å ¬ã®å Žã§ãå šåœæ°ã«åããŠççŽã«ããèšã£ãã
ãäžçã®ãªãŒããŒãã¡ããã®ã³ãã¥ããã£ã§æã¡åºãããšãèããããšãããã¯ãæ©æ¢°ãç§ãã¡ã®æèãèªã¿ã"æèãæ¿å ¥ããææ ãæ¿å ¥ãã" ããšããã§ããå¯èœæ§ã«ã€ããŠã®ãã®ã§ãã 5Gã¯ãšãŠã€ããªã倧ããªé£èºã§ãããªããªãã5Gãã¯ãããžãŒãæå³ããã®ã¯ããããŸã§ã®ãã¯ãããžãŒãæå³ããŠãã以äžã«ãç§ãã¡ã®ç掻ã«å€§ããªå€åãããããããã§ãã
æ©æ¢°ãç§ãã¡ã®æèãèªã¿åãã"æèãæ¿å ¥ããææ ãæ¿å ¥ãã" ããšããã§ãããšããå¯èœæ§ãæäŸããã®ã§ããããã¯åã«ç掻ãå€ããã ãã§ã¯ãªããå€é©ããããããã®ã§ããç§ãã¡ã®ç€ŸäŒã®å®éã®ç¥çµç³»ã«5Gãå°å ¥ããããŸãã«ãã®ãããªããšã§ããããã¯ç§ãã¡ã®åœå®¶ãè¿ä»£åããããšã§ãããåœã®ãã¹ãŠã®å®¶åºã«å±ãå€åãšãªãããšãªã®ã§ãã 96
ç©æ¥µçãªæ€é²ã«ãã£ãŠç§ãã¡ã®å£°ãçã¿ãäžæ£éžæã«ãã£ãŠç¥šãçã¿ãå¢ãç¶ããçšéã«ãã£ãŠãéãçãã åŸã圌ãã¯ä»åºŠã¯5Gã«ãã£ãŠç§ãã¡èªèº«ã®æèãææ ãçãã§ããããããã¯åœŒãã®å°å¶æ¿æ²»ã®é ç¹ãšãªãã ããã圌ãã¯æãæèãææ ãå šäžçã«æŒãä»ããããšãã§ããããã«ãªãããã¯ã誰ã圌ãã«ããçæžãããéžè±ããããšãã§ããªããªãããã ãã ãããããã¯ã©ãŠã¹ã»ã·ã¥ã¯ãã¯è¿æªæ¥ã®ããã¢ãŒã·ã§ã³ã»ãããªã§èªä¿¡ãæã£ãŠããèšã£ãŠããã®ã ã
ãããªãã¯äœãææããããã©ã€ãã·ãŒããªãã幞ãã«ãªããããã97
Page 33
ããããããã圌ãèšã£ãŠããã®ã¯ã人çºçã«èªçºãããåœãã®å¹žçŠã®ç¶æ
ã®ããšãªã®ã§ããããïŒ ãããä»åã®ã¯ã¯ãã³ã¬ããŒããšã©ãé¢ä¿ããŠããã®ãïŒ ä»ãç§ãã¡ãèªèããŠãã以äžã®ããšãããã®ãããããŸããã5Gã人ã
ã®æèãææ
ãå€åãããããã«ã¯ãããã²ãšã€ã®èŠçŽ ãå¿
èŠã§ããããã¯ã人ã
ã®è³ã®äžã«ããããç²åã§ã5Gã®ä¿¡å·ãåä¿¡ãããéä¿¡ãããããã®ã§ãã
5Gã®éä¿¡ã«æã广çãªç©è³ªã¯ãã³ãããæ³šå°ã«å€§éã«å«ãŸããŠããç©è³ªãé žåã°ã©ãã§ã³ã§ããããšã倿ããŠããŸãã 98 , 99
å°çäžã§é žåã°ã©ãã§ã³ã»ã©5Gãšã®éä¿¡ã«åªããç©è³ªã¯ãªãã100ããŸãã人éã®è³ã«æµžéãã人éã®æèãææ ãæäœããã®ã«é žåã°ã©ãã§ã³ã»ã©å¹ççãªç©è³ªã¯ååšããªããã°ã©ãã§ã³ã䜿ã£ãŠäººéã®è³ãæäœããå»çã«åœ¹ç«ãŠãããšããŠããäŒæ¥ã«ãIN BRAIN Neuro Electronics瀟ãååšãããå瀟ã®ãŠã§ããµã€ãã«ã¯ä»¥äžã®èšè¿°ãããã
ãåœç€Ÿã¯ã人éãç¥ãéãæãèãçŽ æã§ããã°ã©ãã§ã³ã䜿ã£ãŠãäžçäžã®æ£è ãå©ããããã®è³ä¿®åŸ©ã®ããã®æ°äžä»£ã®ãã¥ãŒã©ã«ã»ã€ã³ã¿ãŒãã§ãŒã¹ãæ§ç¯ããŠããŸããã
åç€Ÿã®æè¡ã¯ã人ã®è³ããèªã¿ããç¹å®ã®ç¥çµåŠçãã¿ãŒã³ãæ€åºãããã®äººã®ç¥çµåŠãå¶åŸ¡ããŠè³æ©èœãå€åãããããšãã§ãããšåŒ·èª¿ããŠãããã101ãããã ã€ã³ã»ãã¬ã€ã³ç€Ÿã®æå³ã¯ãåã«ç¥çµçŸæ£ãæã€äººã ãå©ããããšã«ããããã ããç§ã圌ãã«èšåããã®ã¯ãã°ã©ãã§ã³ãããã«äººéã®è³ãå€åãããçæ³çãªç©è³ªã§ãããã説æããããã§ããããããŠç¹°ãè¿ãã«ãªããŸãããããã¯äœããã5Gãšã®çžæ§ãè¯ãã®ã§ããã³ãããã®ã¯ã¯ãã³ã«ã°ã©ãã§ã³ãå«ãŸããŠãããšããäºå®ã¯ãããªå€§çµ±é ãè¿°ã¹ããããªäžçã®æå°è ãã¡ã®ææãç¥ã£ãŠãããªãã°ãéåžžã«æ°ã«ãªããšããã§ãã
ã5Gã¯ãæ©æ¢°ãç§ãã¡ã®èããèªãã ããèããæ¿å ¥ããããææ ãæ¿å ¥ãããããããšããã§ããå¯èœæ§ãæäŸããŸããã
ããã²ãšã€è§Šããªããã°ãªããªãã®ã¯ãç§ãã¡ãç¥ã£ãŠãããããªäººé¡ãçµãããã人é¡ããµã€ããŒã°ã«ãããšããã°ããŒããªã¹ãã®æç¢ºãã€å ¬çãªæå³ãªã®ã§ãããã®ããšã¯ãã¯ã©ãŠã¹ã»ã·ã¥ã¯ãã®èæžã第4æ¬¡ç£æ¥é©åœãã«ã¯ã£ãããšæžãããŠããŸãã圌ã¯ã人éã¯ã¯ã©ãŠãã«å®å šã«æ¥ç¶ããã人工ç¥èœã«ãã£ãŠç£èŠã»å¶åŸ¡ãããæ©æ¢°ãšäžäœåããå¿ èŠããããšåŒ·ãä¿¡ããŠãããã ãããã圌ã¯ã誰ãããã©ã€ãã·ãŒã®åœ¢ãæããªããªãããããã圌ãã¯ã幞ããã«ãªããšèšãã®ã ãã·ã¥ã¯ãã¯ãèªåã®çæãé ãããã«å·§åŠã«éžã°ããèšèã䜿ã£ãŠãããã«å·§ã¿ã«éšãæè¡ãç¿åŸããŠãããããåœŒã®æ¬ã®æåŸã«èŠãããšãã§ããã
ãçµå±ã®ãšããããã¹ãŠã¯äººãšäŸ¡å€èгã«åž°çµããŸããç§ãã¡ã¯ã人ã ã第äžã«èãã圌ãã«åãäžããããšã§ãç§ãã¡å šå¡ã«ãšã£ãŠæå¹ãªæªæ¥ã圢æããå¿ èŠããããŸããã
Page 34
æãæ²èгçã§ãäººéæ§ã倱ã£ã圢ã§ã第4次 ç£æ¥é©åœã¯ã確ãã«äººé¡ããããããåãããå¿ãéã奪ãå¯èœæ§ããããããããŸãããããããåµé æ§ãå ±ææ§ãå調æ§ãªã©ã人éã®æ¬è³ªã®æè¯ã®éšåãè£å®ãããã®ãšããŠãéåœå ±åäœã®æèŠã«åºã¥ããæ°ããé壿èãšé埳æèãžãšäººé¡ãåŒãäžããããšãã§ããŸããåŸè ãåã€ããã«ããããšã¯ãç§ãã¡å šå¡ã«èª²ãããã矩åãªã®ã§ããã102
ããã§åœŒãèšã£ãŠããã®ã¯ã人éã¯åãäžããããå¿ èŠããããããããã«ãªã£ãŠã¯ãããªããšããããšã ããããããã®äžã§ãã人é¡ãæ°ããªéå£çã»é埳çæèã«åŒãäžããããšãããã©ã¡ããåªå ãããã¹ãããçµè«ã¥ããŠããŸããããã¯äœãæå³ããã®ã§ããããïŒãã€ãŸãããã¹ãŠã®äººéãåãããã«èããåãããã«æããåããéåæèããå ±æããããã«ãªããšããããšã§ãã
ããã¯ãå šäººé¡ã®è³ãå®å šã«æäœãããããšãæå³ããŸãããã¹ãŠã®äººããäžçã®æå°è ãã¡ãåŠæ¹ããç©èªã«æåŸããããšã«ãªããŸããã人é¡ã¯æ°ããéåæèãæã€ããã«ãªãããšã
ã°ãŒã°ã«ããã§ã€ã¹ããã¯ããã€ãã¿ãŒãããã¯ã誰ãã®å£°ãæ€é²ããå¿ èŠã¯ãããŸããã第4æ¬¡ç£æ¥é©åœã«ãã£ãŠãå šäººé¡ããåãèãæ¹ã«åŒãäžãããããã®ã§ããããããããã®ç¯çœªè ãã¡ã®ç©¶æ¥µã®ç®æšãªã®ã ãã·ã¥ã¯ãæ°ã®åœåã¯æçœã§ããããªããªãã°ãããã¯ãŸãã«åœŒãèµ·ããã¹ãã§ã¯ãªããšèšã£ãŠããããšã ããã ãããã¯ã人éãããã¯ãèªåã§èããããšã®ã§ããªãããããã«å€ããŠããŸãããšã§ãããå šå¡ãåããå¿ããå ±æããããšãäœåãªããããã®ã§ããã
ãã®æå³ã¯æç¢ºã§ãã人é¡ã¯äººå·¥ç¥èœã«æ¥ç¶ããã誰ããäœãèããäœãæããã¹ãããæããŠãããããã«ãªããªããã°ãªããŸããããã®ããã«ã¯ã人é¡ã«ãããã¯ãããžãŒã泚å
¥ãããã¹ãŠã®äººãããããçš®é¡ã®ä¿¡å·ãéåä¿¡ã§ããæ©ãã¢ã³ããã«ããããšãéµãšãªããŸãããããã人é¡ã«çµããã®ãªã泚å°ã課ãçç±ã§ã¯ãªãã ããããé
žåã°ã©ãã§ã³ãã¯ãããšãããããã¯ãããžãŒã®ååšæãé«ãç¶ãã人ã
ããã©ã³ã¹ãã¥ãŒãããºã ã®æ°æä»£ãžãšç§»è¡ãããããã ããããããããããäžççµæžãã©ãŒã©ã ãé廿°å幎ã«ããã£ãŠæšé²ããŠããããšããããŠåœŒãã®æè¿ã®èšäºãæ¬ããããªã§èª¬æãããŠããããšãšå
šãåãã§ãªããšããããç§ã¯ãããæªãæ ç»ã®ã·ããªãªã ãšèããã ãããããããããã¯æ ç»ã§ã¯ãããŸããããã®ãµã€ã³ãã¹ãã¡ãã人é¡ã®æªæ¥ãšããŠçã£ãé ã®äžã§äœãäžããŠãããã®ããçŸå®ãªã®ã§ãã
Page 35
æ°äžçç§©åº
<ãªãŒã¹ãã©ãªã¢ã§ã¯ãã¯ãçå®ãé ããªã>Â
äœå幎ãã®éãæ°äžçç§©åºãšåŒã°ããäžççãªæå§ãšæ¯é ã®å°å¶çãªã·ã¹ãã ã¯ãé°è¬è«ã®ã¬ããã«ã貌ãããŠããŸããããããããã¹ãŠã®é°è¬è«ãããã§ããããã«ãæéãçµãŠã°ãããã¯åãªãçè«ã§ã¯ãªãããšãããããŸãããªãŒã¹ãã©ãªã¢ã§ã¯ãä¿å¥åœå±ã¯ãã¯ãèªåãã¡ã®æå³ãé ãããšãªããèªåãã¡ã®ã³ããã®å°å¶æ¿æ²»ããæ°äžçç§©åºããšåŒãã§ããŸããããã¯ããã¥ãŒã»ãµãŠã¹ã»ãŠã§ãŒã«ãºå·ã®æé«ä¿å¥è²¬ä»»è ã§ããã±ãªãŒã»ã¬ã€ã»ãã£ã³ãæ°ããå ¬éæŸéã§èªã£ãèšèã§ããã
ãæã ã¯ã"æ°äžçç§©åº" ã«ãããé£çµ¡å ã®è¿œè·¡ãã©ã®ãããªãã®ããèŠãŠãããŸãã ãããããã«ããžãã£ããªã±ãŒã¹ãããã°ããããã¯ã©ããªã©ã«ãªãã§ããããã 103
ãªãŒã¹ãã©ãªã¢ã®ä¿å¥å€§è£ã§ãããã©ããã»ãã¶ãŒãã¯æ¬¡ã®ãããªèšèãæ®ããŠããã
ãããã¯ä»æ¹ã®ãªãããšã§ããæã ã¯ããã"æ°äžçç§©åº" ã§ããããšãåãå ¥ããªããã°ãªããªããã 104
ãªãŒã¹ãã©ãªã¢ã®ãã¥ãŒã¹ã¬ããŒã¿ãŒã次ã®ãããªèšèã§æ°ããèŠå¶ãçºè¡šããã
ããŸããä»å€12æãçå€äžã«æœè¡ããã"æ°äžçç§©åº" ã§ã¯ãæ§ã ãªããžãã¹ã«æ°ããªå¶éãå ããããŸããã 105
å¥ã®ãªãŒã¹ãã©ãªã¢ã®ãã¥ãŒã¹æŸéã§ã¯ã次ã®ããã«èšã£ãŠããã
ã "æ°äžçç§©åº" ãããåœã®è»éãè¡é²ããŠããŠãèŠå¯ãšååããŠãåœã®å³ããæ°æ€ç«æ³ãå·è¡ããã®ãå©ãããã 106
æ°ããèŠå¶ãæœè¡ãããæ¥ã«ããã¥ãŒã¹ã¬ããŒã¿ãŒã¯ããèšã£ãã107
ã仿¥ã¯ã"æ°äžçç§©åº" ã®æåã®æ¥ã§ãã å±å€ã§ã®éãŸãã¯2人ãŸã§ãšãããéåã¯èš±å¯ãããŠããããèªå® ããååŸ10km以å ã«ã¯å ¥ããªãããåºãèŠãããšã¯èš±ãããŸãããå¿ èŠãªè²·ãç©ã®ããã«å€åºã§ããã®ã¯ã1äžåž¯ã«ã€ã1人ã ãã§ãã ãããŠãææ¥ããã®è¬åã¯10人ãŸã§ã«å¶éãããŸããã
ãã®é人éçãªå°å¶æ¿æ²»ã®èšãèš³ã¯äœãªã®ã ãããïŒ 2021幎äžåæã®ã³ããã®æ³å®æ»äº¡æ°ã¯14人! äžæ¹ã2017幎ã«ã¯ãªãŒã¹ãã©ãªã¢ã§4,000人以äžãã€ã³ãã«ãšã³ã¶ãèºçã§äº¡ããªã£ãŠããŸãã 108
Page 36
äœã話ã§ã¯ãªãããããæŽå²ã®äºå®ãªã®ã§ãã
<人é¡ã®æŽå²ã¯é°è¬è«ãªã®ãïŒ>
æŽå²ãç¥ãã°ãäžçãæ¯é ããããšãå¯äžã®ç®çãšããæš©å欲ã®åŒ·ãç人ãåžžã«ååšããŠãããšããåºæ¬çãªçŸå®ãçè§£ããããšãã§ããŸããäžåœããã«ã·ã£ãã®ãªã·ã£ãããŒããã¹ãã€ã³ãã€ã®ãªã¹ãªã©ã®äžçåžåœãæãæµ®ãã¹ãŠã¿ãŠãã ãããäžçãæ¯é ããããšããæ¬²æã¯ãäžçãã®ãã®ãšåããããå€ããã®ãªã®ã§ããã ãããããç§ããã®æŽå²çäºå®ãèªããšã人ã ãå²ç¬ãããããªåå¿ãããã®ãèŠãŠããã€ãé©ããããã®ã§ããç§ã®ãŠã§ããµã€ããStopWorldControl.comãã®ååã§ããããã人ã«ã¯éŠ¬é¹¿ã«ãããŸããããããäžçæ¯é ã ãªããŠããã ããªãé°è¬è«ã ïŒããšãããã¯ã人éã®ååšã®æãåºæ¬çãªåçãçè§£ããããšãããç§ãã¡ã®å¿ãã©ãã»ã©é ãã«å°ãããŠãããã瀺ããã®ã§ãããææ ®ãã¹ãããšã§ããæè¿ã§ã¯ã80幎åã«ããäžçãæ¯é ããããšããå¥ã®ç人ã«ãã£ãŠäžçãè ãããããã®çµæã2åã®é£ç¶ããäžç倧æŠãèµ·ãã£ãŠããŸãããããé°è¬è«ã§ããïŒ
äžçå šäœãæ¯é ããããšããèšç»ã¯ã人é¡ã®åç¶æéäžãåžžã«ååšããç¡æ°ã®åœ¢ã§è¡šçŸãããŠããã
ç§ãã¡ã®äžçã®2ã€ç®ã®åºæ¬çãªçŸå®ã¯ããã€ã®æä»£ã«ãæªã®é åã«èº«ãæ§ãã人ã ããããšããããšã§ããæŽå²ãèŠãã°ãéå»ã®å€ãã®ã°ã«ãŒãããååŒçãªåäŸã®çãèŽãçãããŸãŸã®äººã®çŒèº«ã人ã®èžãåãéããŠéŒåããå¿èãåãåããªã©ã®æé»ã®è¡çºã«æ·±ãå ¥ã蟌ãã§ããããšãã¯ã£ããããŠããŸããããã¯äžçäžã®ææã§å ±éããŠããŸãããã»ãšãã©ã®åœããèªåãã¡ã®ãç¥ããšã¿ãªãæªéçååšã®åŽæã«æ²¡é ããŠããããã§ããã€ã³ããã¢ããªã«ãã¢ãžã¢ããšãŒããããã¢ã¡ãªã«......äžçã®ããããå°åã§ããããè¡çºãè¡ãããŠããŸããã
人é¡ã®æŽå²ã®äžã§ã仿¥ã«è³ããŸã§ãããæåã®äžå¿ã«ã¯æ®é ·ã§æãããç¿æ £ããããŸããã
æè¿ã®äžéã¯ãããŸãã«ãã²ã©ãæŽè³ãåããŠããããã§ãçŸä»£ã«ãåããããªéã®å¢åãååšãããšèŠåãããšãããã«åŠå®ããŸããããããç§ãã¡ã®ç掻ãå®ãããã®ã§ããã°ãéå»ã«äžçãææã«é¥ããåçš®ã®éªæªãªååšããä»ãååšããŠããããšãçè§£ããªããã°ãªããŸãããæ°äžçç§©åºã®èåŸã«ããç¯çœªãããã¯ãŒã¯ã®äžå¿ã«ã¯ããã®ãããªéªæªãªäººã
ãããã®ã§ãã
Page 37
ãã®ç¯çœªè
ãã¡ã¯äœè
ãªã®ãïŒ
<äžçãæ¯é
ããããŒã¯ã»ãã¡ããªãŒãšã¯>
ãã®ç¯çœªè ãã¡ã¯ãã£ãã誰ãªã®ãïŒåœŒãã®ååãå± å Žæã¯ããã£ãŠããã®ãïŒåœŒãã¯ã©ã®ããã«æŽ»åããŠããã®ããç§ãã¡ã¯åœŒããæ¢ããããã«äœãã§ããã®ãããã®çãã®éèŠãªéšåã¯ãStopWorldControl.com ã§èŠãããšã®ã§ãã壮倧ãªããã¥ã¡ã³ã¿ãªãŒãMONOPOLYãã«ãããŸãã
ãMONOPOLYãã¯ããã®äžçã®ãããããã®ãåã人éã«ãã£ãŠæ¯é ãããŠããããšããã¹ã¯ãªãŒã³ã«æ ãåºããããã¹ãŠã®èšŒæ ãããšã«ãè©³çŽ°ã«æããã«ããŠããŸãã圌ããäœè ãªã®ãããããŠåœŒãã人é¡ã«å¯ŸããŠäœãèšç»ããŠããã®ãã瀺ããŠããŸãã ãã²ã芧ãã ããã
ãããã®è¶ å¯è£å±€ã¯ãã¹ãŠãææããŠãããããäžçãæ¯é ããã®ã¯ç°¡åãªããšãªã®ã§ããã¢ããã«ããã§ã€ã¹ããã¯ããã€ãã¿ãŒãã°ãŒã°ã«ããã§ã€ã¹ããã¯ãªã©ã®ããã°ããã¯ãäž»èŠãªãã¥ãŒã¹ã¡ãã£ã¢ãæ è¡æ¥çãé£åæ¥çãéè¡ãè¡£æåæ¥çãªã©ãææããŠããŸãããããããã®ãæŠç¥çã«è³Œå ¥ããããšã§ã圌ãã¯äžççã«æ¯é¡ã®ãªãç¬å ç¶æ ãæã«å ¥ããã®ã§ãããŠãªãŠã¹ã»ã·ãŒã¶ãŒã倢ã§ã¯ãªãã£ãã§ãããããŸãã圌ãã¯å»çæ¥çå šäœãææããŠãããäžçäžã®ç é¢ã«äœããã¹ãããäœããã¹ãã§ãªãããæç€ºããããšãã§ããŸãã圌ãã¯ãéžæã§ã®äžæ£è¡çºãèŽåè³ãè è¿«ãéããŠãäžçäžã®æ¿åºã«æ¿æ²»çãªæã人圢ãé 眮ããŠããŸãããã®ããšãçè§£ããã°ã圌ããããã«ããŠäžçäžã«å°å¶æ¿æ²»ãæ·ãããšãã§ããããããããŸãã
é¢ä¿ããåã ã®å£äœã®ååããã¹ãŠæããã®ã¯ãšãŠãç¡çã§ããããã®ãããã¯ãŒã¯ã®äžå¿ãšãªã£ãŠããå£äœãããã€ã玹ä»ããŸããäŸãã°ãã€ã¿ãªã¢ã«ã¯ "é»ã貎æ "ãšåŒã°ãã13ã®å®¶æãè¡çµ±ããããç§ã¯ããããã¹ããã€ãã®ããã£ã¢ããšåŒãã§ããŸãããããã®äžæã¯ãå°çäžã®ä»ã®å°åã®åæ§ã®çæãšãšãã«ãèªåãã¡ãä»ã®äººéãããåªããŠãããšèããŠããŸãã圌ãã¯äžè¬ã®äººã ããè«ãããå®¶çãããç¬ããšèŠãªããŠããŸãã圌ãã®æç®ã«ã¯ãæåéãããªããç§ã®ããšãæžãããŠããŸãã
圌ãã¯ã人é¡ãæ¯é ããããšãèªåãã¡ã®éåœã§ããã人é¡ã¯åœŒãã®å¥Žé·ã«ãªãã¹ãã ãšä¿¡ããŠããã®ã§ãã
ãããã®ãã¡ããªãŒã¯ãã©ãããåã®ããšã©ã«ããŒã§æ§æãããŠãããæçµçã«ã¯å
šå¡ããããã®åãæã人圢ã«åŸãããšã«ãªããŸãã圌ãã®åã®ç§èš£ã¯ç§å¯äž»çŸ©ã§ããã誰ã圌ãã«æãåºããªããã ãããããçã®ãªãŒããŒã¯åžžã«åœ±ã«é ããŠããã®ã ãäžçã®äººã
ãç®ã«ããã®ã¯ããã€ã³ãããã°ã©ã ãããæ¿æ²»å®¶ãããªãŠããã®ã»ã¬ããç£æ¥çã®ãªãŒããŒãã¡ãã£ã¢ã®ããŒãœããªãã£ãªã©ãäžçã®è¡šèå°ã§æŽ»èºããæã人圢ã ããªã®ã§ããããç¥ãããŠãããšããã§ã¯ãã¯ã©ãŠã¹ã»ã·ã¥ã¯ãããã«ã»ã²ã€ãããžã§ãŒãžã»ãœãã¹ãã¯ãªã³ãã³å€«åŠ»ãããã·ã¥å®¶ãªã©ããããŸãã圌ãã¯åã
ã«ã¯éåžžã«è£çŠã§åŒ·åãªåãæã£ãŠããŸããã以äžã®ãããªç¹åŸŽããããŸãã圌ãã¯ãããäžäœã®çµç¹ã«å±ããŠããŸããããã®çµç¹ã¯èªåãã¡ã衚ã«åºãªãããã«ããŠããŸããç§å¯äž»çŸ©ã圌ãã®åŒ·ã¿ãªã®ã§ãã
Page 38
圌ãã®æŠç¥ã®1ã€ã¯ãå ¬çãªãäžçãçµç¹ãèšç«ããããšã§ããã圌ãã®ã¢ãžã§ã³ããå®çŸããããã®ç®ã«èŠãããã©ãããã©ãŒã ãšãªã£ãŠããŸãããã®äžã€ããä»åã®çµç¹çãã³ãããã¯ã§éåžžã«ç®ç«ã€ããã«ãªã£ããäžçä¿å¥æ©é¢ãã§ããããã®ç¯çœªãããã¯ãŒã¯ã®éèŠãªæã人圢ã§ãããã«ã»ã²ã€ãããã®ã»ãšãã©ãåºè³ããŠãããèããŠã¿ãŠãã ããïŒWHOã¯ãç§ãã¡ãå¥åº·ã«é¢ããŠã§ããããšãã§ããªãããšãå šäººé¡ã«æç€ºããŠããã®ã§ãã誰ãWHOãéžãã§ããªããã誰ãWHOã®ååšãæãã§ãããªãã®ã§ãã
WHOã¯ãå šäžçã®äººã ã«ãé©åãªç§åŠã«åºã¥ããŠãããšãããããããããåç§åŠçã§ããããšãå€ãã圌ãã®å°å¶çãªãã¬ã€ãã©ã€ã³ãã«ãçãããšãªãåŸãããšã匷èŠããŠããŸãã
äŸãã°ãWHOã¯å šäžçã«åããŠãã³ãããã®çäŸãçºèŠããããã«PCRæ€æ»ã䜿çšããããã«æç€ºããŸãããããã®æ€æ»ã¯ç°ãªãçš®é¡ã®ç åäœãèå¥ããããšãã§ãããæå€§ã§93ïŒ ã®åœéœæ§ãçºçããŸãããã®æ¬ é¥ã®ããæ€æ»ã¯ããã³ãããã¯ã®çºçãäžçã«äŒããããã®äž»èŠãªããŒã«ã§ãããããã»ã©ä¿¡é Œæ§ã®äœãå»çæ©åšã¯æŽå²äžãããŸããã§ããããããããã®åç§åŠçãªãããã³ã«ã¯ãäžççãªãã³ãããã¯ã®å¹»æ³ãä¿é²ããããã«ãå šäžçã«æŒãä»ããããŠããŸãããããã¯äž»ã«åœéœæ§ã«åºã¥ããŠããŸããäœåãã®ãããããã³ãŽã£ãçäŸãã¯ãèŽåœçãªæ¬ é¥ã®ããæ€æ»ã®çµæãåœéœæ§ãšãªã£ãã«éããªããå®éã®ãŠã€ã«ã¹ã§ããSars-Cov-2ã¯åé¢ã»ç²Ÿè£œãããŠããªãã®ã§ãæ€æ»ããããšã¯äžå¯èœãªã®ã§ããããã¯å€©æåŠçãªèŠæš¡ã®è©æ¬ºã§ããã
ããã¯ããå¥åº·ãå®ãããšããåç®ã§ã人é¡ãå°å¶æ¿æ²»ã«æåŸããããšããã¢ãžã§ã³ããå±éããããã«ããäžççµç¹ããå©çšãããŠããäŸãªã®ã§ãã
䌌ããããªçµç¹ã«åœéé£åããããŸããåœéé£åã¯ãããããäžçã®ãå¹³åã®çªäººããèªç§°ããŠããŸãããããã圌ãã®ç®çã¯ãå šäººé¡ãäžã€ã®äžçæ¿åºã«åŸãããããšã§ããåœé£ã¯ãEUãNATOãšå¯æ¥ã«é£æºããŠããŸãããããã®çµç¹ã¯ãç¯çœªè äžæã«ãšã£ãŠãååœã®ç¬ç«æ§ãæé€ããåäžäžçã®æ¿åºãèšç«ããããã®åæ§ã®ã«ã«ãŒã»ã«ïŒå転æšéЬïŒãªã®ã§ãã
ããã²ãšã€ã®å
¬çæ©é¢ã¯ãã¯ã©ãŠã¹ã»ã·ã¥ã¯ããèšç«ãããäžççµæžãã©ãŒã©ã ãã§ããäžççµæžãã©ãŒã©ã ã¯ãäžçã®å¯è£å±€ãšæš©åè
ã®ããã®ã·ã³ã¯ã¿ã³ã¯ã§ããããäžçã®åé¡ã®è§£æ±ºçãæš¡çŽ¢ãããããšãç®çãšããŠããŸãã圌ãã®éæ³ã®èšèã¯ãæç¶å¯èœãªéçºãã§ãããäžçã®ããè¯ãæªæ¥ãä¿èšŒãããšäž»åŒµããŠããŸããåœé£ãšå
±åã§ãã¢ãžã§ã³ã21ããçå®ããæç¶å¯èœãªäžçãå®çŸããããã®ç©¶æ¥µã®ãœãªã¥ãŒã·ã§ã³ãæäŸãããšäž»åŒµããŠããŸãã Â
Page 39
çŸå®ã«ã¯ãå šäžçã®äººã ãããã¹ãŠã®æš©å©ãèªç±ã財ç£ã奪ãããã¹ãŠãè¶ å¯è£å±€ã®æã«æž¡ãããšã«ã»ããªããŸããã
ãããŠãäžçã®ãã¹ãŠã®ãéã管çããéè¡åžåœããããŸãã圌ãã®ä»äºã¯ããã£ãã·ã¥ã¬ã¹ç€ŸäŒãå®çŸããããšã§ãç£èŠãšå¥Žé·ã®ã·ã¹ãã ã«ããžã¿ã«ã§æ¥ç¶ããã人ã ãããéèæ©é¢ã«ã¢ã¯ã»ã¹ã§ããããã«ããããšã§ãããã€ãžã§ãªã¢æ¿åºã¯ã圌ãããå€é¡ã®å ±é ¬ãåŸãŠãéè¡ãµãŒãã¹ãäºé²æ¥çš®ãåãã人ã«éå®ããŠããŸããããã®äŸã¯ããã«ä»ã®åœã远éããã§ããããéè¡åžåœã®ä»£è¡šçãªååšã¯ãæªåé«ããã¹ãã£ã€ã«ãå®¶ã§ãã圌ãã¯165ã«åœã®äžå€®éè¡ãææããŠãããäžçã®ã»ãšãã©ã®åœã®ãéã®æµããã³ã³ãããŒã«ããŠããŸããå€ä»£ãããã®äžæã¯ããã¹ãŠã®åã®äžã§æãæããã®ãåŽæããããšã«èº«ãæ§ããŠããŸãããããäžã€ã®æåãªãã¡ããªãŒã¯ããã¯ãã§ã©ãŒå®¶ã§ãã圌ãã¯2010幎ã«ãæªæ¥ã®ã·ããªãªããçºè¡šããçŸåšã®ãã³ãããã¯ã詳现ã«èª¬æããæ¯é ãšã³ã³ãããŒã«ã®æ°ããäžçã確ç«ããããšãç®çãšããŠããŸãã
ããã¯ãã§ã©ãŒç ç©¶æã®ãããªçµç¹ã¯ãèªãã人é¡ã®ä¿è·è ã®ããã«èŠããŠããŸããããã®äººéçãªä»®é¢ã®è£ã«ã¯ãæš©åæ¬²ãšããæãããé¡ããããŸãã
ã€ã¿ãªã¢ã®é»ã貎æã«ã€ããŠã¯ãã§ã«è¿°ã¹ãŸããã圌ãã®æã广çãªæŠç¥ã¯ãããªã¹ãæã®çŸããé¡ã®åŸãã«é ããããšã§ããã圌ãã¯ãããŒãã»ã«ããªãã¯ã®äžå¿ããšããŠããŒãã®ããã«ã³ãèšç«ããŸããããããã倧èå ã®ãããªèšå¿µç¢çãªå»ºç¯ç©ã®èåŸã«ã¯ãæ®éã®äººéã«ã¯çè§£ã§ããªãã»ã©æãåé¯ããäžçãæœãã§ããŸããæè¿ããã®å®æçæ ç¹ã§çµç¹çã«è¡ãããŠããå ç«¥èåŸ ãæãã¿ã«åºãŸããããããã¯æ°·å±±ã®äžè§ã«éãããããã§èµ·ãã£ãŠããããšãç¥ãã°ãã»ãšãã©ã®äººããã©ãŠãã«ãªã£ãŠããŸãã§ããããããã«ã³ã«ã¯ãåè¯ãªå®æå®¶ãããã®ã§ãããè£ã§äœãèµ·ãã£ãŠããã®ããç¥ããªãã ããªã®ã§ãã
ããã¯å·šå€§ãªäººåœ¢åã§ããã倧倿°ã®äººã ã¯ãå æ ããŠãã人ã ãå«ããŠãäœãèµ·ãã£ãŠããã®ããã©ã®ããã«çãæãããŠããã®ããå šãçè§£ã§ããŠããªãã®ã§ãã
ããã«ã³åžåœã®äžã«ã¯ãã€ã¿ãªã¢ããç¬ç«ãã䞻暩åœå®¶ã§ããããã«ã³åžåœããããããã§ã¯ã€ã¿ãªã¢ã®æ³åŸã¯äžåã®æš©éãæã£ãŠããªããããã§ã¯ãåšå²ãåãå²ãã€ã¿ãªã¢ã©ããããã©ã®åå°ã®æ³åŸã«ãæåŸããªããããã©ããªç¯çœªãå¯èœãªã®ã§ãã䌌ããããªåœå®¶ã®äžã®äž»æš©åœå®¶ãšããŠã¯ããã·ãã£ã»ãªãã»ãã³ãã³ãïŒãã³ãã³ã®äžã®ç¬ç«åœå®¶ã§ãè±åœã®æ³åŸããã¹ãŠåé¿ããŠããããè±åœæ¿åºãæ¯é
ããŠããïŒããã¯ã·ã³ãã³D.C.ãïŒç±³åœã®äžã®äž»æš©åœå®¶ã§ãç±³åœæ°ãæ¯é
ããŠããã³ãã³ãã¢ç¹å¥åºïŒãªã©ããããŸããç¯çœªè
äžæã¯ããã®ãããªæã®ã€ããããªããåœå®¶ã®äžã®åœå®¶ããèšç«ããããã§æŽ»åããŠããã®ã§ãã
Page 40

ããã«ã³åžåœã¯ãã®äžã§ãæãéèŠãªéœåžã§ãããæé«ã®æã人圢垫ãã¡ãããã«åžã眮ããŠããã®ã§ãã
ç§ãã¡ã¯ããã©ã³ã·ã¹ã³æ³çãæŒããŠããããã¯ã€ãã»ããŒãããç¥ã£ãŠããŸãã圌ã®ä»äºã¯ãäžçäžã®ããŒãã»ã«ããªãã¯æåŸãæ¯é ããæ°äžçç§©åºãžãšå°ãããšã§ããããã€ãã®å ¬ã®ã¡ãã»ãŒãžã®äžã§ã圌ã¯ãã¹ãŠã®ä¿¡è ã«ã¯ã¯ãã³ãæ¥çš®ããããã«åŒã³ããã112   äžçã®åé¡ã解決ããå¯äžã®æ¹æ³ãšããŠæ°äžçç§©åºã宣èšããŠããŸãã以äžã¯ã圌ã®çºèšã®äžéšã§ãã113
ãç§ãã¡ã¯ãæ°ããäžçç§©åºãæ§ç¯ããããšã§ãäžæ£ãçãããšãã§ããŸãã»ã»ã»ã人é¡ã®ææžãžã®éã¯ãçºå±ã®æ°ããã¢ãã«ã®åµé ãéããâŠå人çã«ãæ¿æ²»çã«ãæ ¹æ¬çãªéžæãããŠãå°çã倧åã«ãã...å šäœçãªããžã§ã³ããªããã°ãæªæ¥ã¯ãªã...è¿èŠçŒçãªãã·ã§ããªãºã ã«çµæ¢ç¬Šãæããªããã°ãªããªã...ãã
çœã®æ³çã®ä»ã«ããã匷åãªåãæã¡ãªããè£æ¹ã«åŸ¹ããé»ã®æ³çãããããšã¯ããŸãç¥ãããŠããªãããããã黿³çã¯ãããé«ãäœã«ããç°è²æ³çã«åŸå±ããŠããããã®æé«ã®æã人圢垫ã¯ãå®å
šã«åœ±ã§æŽ»åããŠãããããããäžçã«å¯ŸããŠå·šå€§ãªåãçºæ®ããŠããããã®ãããªæŽå²çãªçµç·¯ãçè§£ãããã®ã§ããã°ãã€ãšãºã¹äŒã®æã粟ç¥çãªèµ·æºã調ã¹ãªããã°ãªããŸããããã®è©±é¡ã¯ç°¡åã«è¡ãéããŠããŸãã®ã§ãä»åã¯ãããŸã§ã«ããŠãããŸãã
Page 41
ç§ãã¡ã¯ããã®ç¯çœªãããã¯ãŒã¯ããéåžžã«ã¹ããªãã¥ã¢ã«ãªæ§è³ªãæã£ãŠããããããã«ç«ã€è ã¯çãå€ä»£ã®æã粟ç¥ä¿®è¡ã«é¢ãã£ãŠããããšãçè§£ããªããã°ãªããŸãããççŽã«èšãã°ã圌ãã¯ã«ã·ãã§ãªã¢ã³ãšãåŒã°ãããµã¿ãã¹ãã§ãããããã圌ãã®æŠç¥ã¯ãåžžã«å£®å€§ãªä»®é¢ã®åŸãã«é ããèªåã®æ£äœãšã¯æ£å察ã®ãã®ãèŠããããšã§ãã
ã¯ã©ãŠã¹ã»ã·ã¥ã¯ãã¯ãã人é¡ãéåæèã«åŒãäžããããšããéåŒãªçè«ãçšããŠäžçäžã®èŽè¡ã®å¿ãé äºããå°çäžã®ãã¹ãŠã®äººéããŸã£ããåãããã«èããæããããã«ããããšãæãåŽé«ãªç®çã§ãããšä¿¡ã蟌ãŸããŠããŸãã
ãããããã®çã£ãèšç»ã®çºè¡šæ¹æ³ã¯éåžžã«ç¡çŸã§ããã圌ã®ã¹ããŒããèããåŸãã»ãšãã©ã®äººã¯ã¹ã¿ã³ãã£ã³ã°ãªããŒã·ã§ã³ãããã ãããçœäººã®ããŒãæ³çãåæ§ã§ãè²§ãã人ã ãžã®é æ ®ãäžå ¬å¹³ã®è§£æ¶ãå°çã®ä¿è·ãªã©ã®åŽé«ãªç®çãçŸããèªã£ãŠããŸãããå®éã«ã¯ãå šäžçã®äººã ãäžã€ã®äžçæ¿åºã®å¥Žé·ã«ãªãå¿ èŠããããããã§ã¯èª°ã声ãäžããããšãã§ãããæš©å©ãèªç±ãææç©ãã¢ã€ãã³ãã£ãã£ããã©ã€ãã·ãŒãæã€ããšãã§ããªãããšèšã£ãŠããã ãã§ããã¯ã¯ãã³ã®çŸ©ååã«äœ¿ãããå¬ç è¡ãšåãã§ããäžçã¯èŽåœçãªç æ°ã«è¥²ãããŠããŸãããç§ãã¡ã«ã¯åœãæãã¯ã¯ãã³ãšããçŽ æŽããã解決çããããŸããäžæ³ïŒãããã®çŽ æŽãããã¯ã¯ãã³ã«ã¯ãè§Šæãæã£ãçãç©ããèªå·±çµç¹åããããç²åãçæ¯ç©è³ªãå«ãŸããŠãããããã«ãã£ãŠäœçŸäžäººãã®äººã ãåœãèœãšããŠããããšã¯ããã¡ããèšåãããŠããŸããã
ãã¹ãŠã¯ç²Ÿè£œãããåœåãšæ¬ºçãçšããŠäººéã«å¬ç è¡ãããããããªã®ã§ãã
ãããã®ç¯çœªè ãæŽ»åããããäžã€ã®æ¹æ³ã¯ãããããç§å¯çµç€Ÿãçµç¹ããŠãããããåœã§é ãã圱é¿åã確ç«ããããšã§ããå®å šã«é ããã瀟äŒãšã¯å¥ã«ãããªãŒã¡ã€ãœã³ã®ãããªå ¬ç¶ãšããã«ã«ãããããŸããããã¯ãããç¥ãããŠãã粟ç¥çãªçµç¹ã®äžã€ã§ãããããåœã®ã»ãŒãã¹ãŠã®çºã®å°æ¹èªæ²»äœã«åœ±é¿ãäžããããã«äœ¿ãããŠããŸãã圌ãã¯ã人é¡ãå©ããããšããç¡å®ã®çµç¹ã§ãããšäž»åŒµããŠãæš©åè ãã¡ãæ¹ãã€ããŸããããªãŒã¡ã€ãœã³ã®é«ãã¬ãã«ã«ç»ã£ãŠåããŠãã¡ã³ããŒã¯ãããæªéåŽæã§ããããšãç¥ãã®ã§ãã
ããªãŒã¡ã€ãœã³ã¯ãåå°åã®æåè ãã¡ã³ããŒã«ããŠãèªåãã¡ã®èšç»ãå®è¡ããããã«å©çšããããšãéèŠããŠããŸãã
ã°ãŒã°ã«ã®å
éšåçºè
ã§ããã¶ãã¯ã»ãŽã©ãŒãªãºã109ãã¯ãå人çãªäŒè©±ã®äžã§ã2016幎ã«ã°ãŒã°ã«ã人é¡ãããã°ã©ã ããèšç»ãããµã³ãã©ã³ã·ã¹ã³ã®ããªãŒã¡ã€ãœã³æ¬éšãšããæãããªå Žæã§èª¬æãããšèªã£ããããã§ã¯ãã°ãŒã°ã«ãã人é¡ã®å¿ã圢æããããšããäŒç€Ÿã®æŠç¥ãã¹ã¿ããã«äŒããŠãããšãããããã¯ãããªãŒã¡ã€ãœã³ããã®äžççãªã¢ãžã§ã³ãã«ãããŠããã«äžå¿çãªåœ¹å²ãæãããŠãããã瀺ããŠããŸãã
Page 42
å€ãã®ç§å¯çµç€Ÿã¯ãäŸãã°ã¢ã¡ãªã«ã®CIAãFBIã®ããã«ãååœã®ã·ãŒã¯ã¬ãããµãŒãã¹ãšå¯æ¥ã«é£æºããŠããŸãã衚é¢äžã¯ç¯çœªãšéã£ãŠããããå®éã«ã¯ç¯çœªçµç¹ã®äžã§ãææªã®éšé¡ã«å ¥ãçµç¹ã§ããããã€ãã®èåãªãžã£ãŒããªã¹ãããŠãã»ãŠã«ãã³ããã¯ãæ°å¹Žåã«ãäžçäžã®ãžã£ãŒããªã¹ããã·ãŒã¯ã¬ãããµãŒãã¹ãç§å¯çµç€Ÿãæ¿åºæ©é¢ãåäžé·è ãªã©ããå ±é ¬ãåŸãŠãåžžã«åãã€ããåœæ°ã«çå®ãèªããªãããã«ããŠããããšãèªããŸããã圌ã®éèŠãªèšŒèšã¯ãStopWorldControl.com ã®ããã¥ã¡ã³ã¿ãªãŒçªçµãBUSTEDãã§èŠãããšãã§ããŸãããšãŒãããæå€§çŽã®æ°è瀟ã®ç·šéè ã ã£ããã®åæ¢ãªãžã£ãŒããªã¹ãã®åçœã®ãããã§ããã€ãã§ã¯å€§ããªç®èŠããèµ·ãã£ãŠããŸããåœŒã®æ¬ã¯ããã€ãã®äººã ã®ç®ãéããã圌ãã¯ä»ãæ°äžçç§©åºã«å¯Ÿæãã倧ããªåãšãªã£ãŠããŸãã
ããã«ã³åžåœãã¯ã·ã³ãã³D.C.ãã·ãã£ã»ãªãã»ãã³ãã³ãç¯çœªè äžæã®æ¬æ å°ã§ããã圌ãã®ç©æµæ¥åã®å€ãã¯ã¢ãžã¢è«žåœã«ç§»ãããŠããŸãããªããªãã圌ãã¯äžåœãå©çšããŠäžçã転èŠãããããšããŠããããã§ãã圌ããäžåœã«å°å ¥ããå®å šãªå¥Žé·å¶ãšæ¯é ã®æå§çãªå ±ç£äž»çŸ©äœå¶ã¯ãä»ãäžçã®ä»ã®åœã ã«å±éãããããšããŠããŸãã
ããããç§ãã¡ã®æµã¯äžåœå ±ç£å ã§ã¯ãããŸãããæã人圢ã§ããäžåœå ±ç£å ã§ã¯ãªããããã«ã³åžåœã«ããæš©åè ãã¡ãªã®ã§ãã
è¯ããã¥ãŒã¹ã¯ããã®ç¯çœªãããã¯ãŒã¯ã«ã¯å€ãã®å çŽããããäžçåŸæã®ããã«ç«¶äºããŠããããã€ãã®é£å¶ã«åãããŠåŽ©å£ããŠãããšããããšã§ãã圌ããèªãã®èœãšã穎ã«èœã¡ãèšç»ãæšãã«å€±æããããã«ã圌ãã®éã§ãã®æ··ä¹±ãå¢ããŠãããŸãããã«ã
ãã®ç¯çœªãããã¯ãŒã¯ã«ã€ããŠã¯ãå€ãã®ç ç©¶è ã人çã®ãã¹ãŠããããŠæŽé²ããå€ãã®æ¬ãæžãããŠããã®ã§ããã£ãšå€ãã®ããšãèªãããšãã§ããŸãããã£ãšè©³ããç¥ãããæ¹ã¯ããªã©ã³ãã®ãŠã§ããµã€ãEllaster.nlã§ãåªããç ç©¶è ãã¡ããŸãšãã質ã®é«ãæ å ±ãè±å¯ã«æ²èŒãããŠããŸããèšäºãèªãã«ã¯Google翻蚳ããå©çšãã ãããhttps://www.ellaster.nl/category/val-van-cabal/cabal
ãŸããStopWorldControl.comã®ããã¥ã¡ã³ãã·ãªãŒãºãFall of CabalããèŠãããšãã§ããŸãããã®ããã¥ã¡ã³ã¿ãªãŒã¯ããã®äžççãªãã«ãã«ãã«ã€ããŠå€ãã®ããšã説æããŠãããžã£ãŒããªãºã ã®åäœã§ãã
Page 43
å倧ãªãèŠé
<äœå人ãã®äººã
ãç«ã¡äžãã>
人é¡ã«ã¯åžæãããã®ã§ããããïŒãããŸãããã®äžã®èªç以æ¥ãæå€§ã®ç¯çœªè¡çºãç®ã®åœããã«ããŠããŸããããããšã¯å šãç°ãªãããšãèµ·ãã£ãŠããŸããäœå人ãã®äººã ããç¡ç¥ãšæ¬ºçã®æ·±ãç ãããç®èŠããäžçäžã§çå®ã®å£°ãäžããŠããã®ã§ããäžçååœã§ãå»åž«ãåŒè·å£«ãç§åŠè ãªã©ãããããå°éå®¶ã«ããçµç¹ãèšç«ãããèªç±ãæ±ããŠæŠã£ãŠããŸãã圌ãã¯ãæè²ãåãã圱é¿åãæã¡ãæ ç±ãæã£ãäœäžäººãã®å°éå®¶ã§æ§æããããã®æ¥µæªééãªèšç»ã黿¢ããããšããŠããŸããçæ°ããã¡ãã£ã¢ãã©ãããã©ãŒã ãçãŸãããã®åœ±é¿åã¯æ¥ã é«ãŸã£ãŠããŸãã圌ãã¯ãç¯çœªã«ã«ãã«ã®ææã§ã¯ãªããã«ã«ãã«ã«ãã£ãŠéå¶ãããŠããç Žå£çãªãã§ã€ã¯ãã¥ãŒã¹ã¡ãã£ã¢ã®çæ»ãã人é¡ãå®ããããšããå¿ææ°ã§æŽ»åããŠããŸãã
ããã«å ããŠããŸããŸãå€ãã®å»çåŸäºè ãã¯ã¯ãã³æ¥çš®ã®çŸ©ååãæåŠããŠããŸããã«ããã§ã¯ã35,000人ã®å»çåŸäºè ãã¯ã¯ãã³ã«æè°ããŸããã59ããã¥ãŒãšãŒã¯ã§ã¯ã83,000人ã®å»çåŸäºè ãæå®³ãªæ³šå°ãæåŠããŠããŸãã60ãã¢ã¡ãªã«å šäœã§ã¯ãå šå»åž«ã®58ïŒ ãå±éºãªæ³šå°ãåããŠããŸããã61ãã«ãªãã©ã«ãã¢å·ã§ã¯ãå šæ³å·è¡æ©é¢ã®50ïŒ ããããã®ç¯çœªçãªçŸ©åã«å察ããŠããŸãã 62
ãããã¯ãäžçäžã®åœã ã«ããã倧éã®ã³ã³ãã©ã€ã¢ã³ã¹éåã®ã»ãã®äžäŸã«éããŸããã
ãã®æµæã¯ãããã«äžçäžã§ççºããããšããŠããŸãããªããªããããã°ããã¯ã倧æè£œè¬äŒç€Ÿãæ¿åºæ©é¢ããã¥ãŒã¹ã¡ãã£ã¢ãªã©ã®ç¯çœªçãªã¯ã¯ãã³ã«ã«ãã«ãæ å ±ãé èœããããšããŠããã«ããããããããã®æ³šå°ã«é¢ããçå®ãåºãæ®åããŠããããã§ãããã®æ å ±ãæããããšããç¯çœªçãªã¯ã¯ãã³ã«ã«ãã«ã®è©Šã¿ã«ããããããããã®æ³šå°ã«é¢ããçå®ã¯åºãæ®åããŠããŸãã
StopWorldControl.com ã§ã¯ããã®ç¯çœªè¡çºã«æµæããŠããäžçäžã®åœã ã®äœçŸãã®çµç¹ã瀺ãäžçå°å³ãçºè¡šããããšããŠããŸãã圌ãã¯ãç¯çœªè ã®å¥Žé·ã«ãªãããšãæåŠããäœå人ãã®äººã ã®ä»£è¡šã§ãããã®äžã«ã¯ãå€ãã®å»åž«ãç§åŠè ãåŠè ãåŒè·å£«ãèµ·æ¥å®¶ãæ¿æ²»å®¶ãªã©ãå«ãŸããŠããŸããåäŸã®ãªããæ¢ãã«æ¢ãŸãã¬ç®èŠããèµ·ãã£ãŠãããããã¯è¿ãå°æ¥ãããã«å¢å€§ããã§ãããã
ç¯çœªè ãã¡ãéªæªãªèšç»ãé²ããããšãããã³ã«ãäœçŸäžäººãã®äººã ãç®ãèŠãŸããŠããããšã¯æããã§ããäŸãã°ãæ°åå€åã®ããã¯ãåœæ°ã«ãããªã管çãšçšéã課ãããã®ããªãã¯ã®äžã€ã«éããŸããã Â
Page 44
ç¥èã®ãã人ãªã誰ã§ãããžãªãšã³ãžãã¢ãªã³ã°ã«ãã£ãŠãæ°åã100ïŒ ã³ã³ãããŒã«ãããŠããããšãç¥ã£ãŠããŸãã 110
å°çæž©æåãªã©ãšãããã®ã¯å··ã§äºãããŠãããããªçŸè±¡ã§ã¯ãªããç§ãã¡ãç®ã«ããŠããã®ã¯ãé«åºŠã«çºéããæ°è±¡æäœã«ãããã²ãšã€ã®äžççãªã·ã¹ãã ã§ãããããããã¹ãŠã®åµãç±æ³¢ãå±±ç«äºãå°éãæ¥µç«¯ãªé¹ãéªã®åµã措氎ããã®ä»ã®èªç¶çœå®³ãåŒãèµ·ãããŠããã®ã§ããäŸãã°ãååŠç©è³ªãç©ºã«æ£åžããŠå€§éšãéãããã¯ã©ãŠãã·ãŒãã£ã³ã°ãããç¥ãããŠããŸãã111ãã¢ã¡ãªã«æ¿åºãè»ãäœæããå ¬åŒææžããããªæ åã«ã¯ãæ°è±¡ã100ïŒ ã³ã³ãããŒã«ãããŠããã ãã§ãªããå µåšåãããŠããããšãæèšãããŠããŸããæ¿åºãè»ãæ°éäŒæ¥ã¯ãäœå幎ãåããæ°è±¡æäœã·ã¹ãã ãæ¹è¯ããŠããŸãããç¯çœªè ãã¡ã¯ãããã«ãå°çæž©æåã ïŒããšå«ãã§ããŸããã圌ãã®ã²ãŒã ã¯å€±æã«çµããã€ã€ãããŸããæ°è±¡æäœïŒãžãªãšã³ãžãã¢ãªã³ã°ïŒã®çå®ãæããã«ãªã£ãŠããããã§ãããã³ãããã¯ãã©ã®ããã«ä»çµãŸããŠããããç¥ã£ãäœå人ãã®äººã ãã人é¡ã«å¯Ÿããä»ã®æ»æãåãåå ã§è¡ãããŠããããšãçè§£ãå§ããŠããŸãããŸããå®å®äººã®äŸµç¥ãšããæ¶ç©ºã®è åšã¯ãå°æ¥ããŒãã«ã®äžã«æãåºãããã§ãããç¯çœªè ãã¡ã®è¢ã®äžã§ããå®å®äººãå°çã䟵ç¥ãã«æ¥ãïŒããšãæã ãå®ãããã«ã¯ãäžã€ã®äžçæ¿åºãå¿ èŠã ïŒããšããã®ã«ãŒãã«ã©ãã ãã®äººãéšããããã芳å¯ããã®ã¯é¢çœãã§ãããã
æŠç¥ã¯ãã€ãåãã§ãåé¡ïŒãã³ãããã¯ãæ°åå€åã人皮差å¥ã瀟äŒäžå®ããšã€ãªã¢ã³ã®è åšãå°ææè¡çªãªã©ïŒãäœãã解決çãæç€ºããã解決çã¯ãã€ãåãã§ã人ã ããå®ãããšããåç®ã§ã人ã ããæš©å©ãèªç±ã財æ¿ã奪ãããšã§ãã
ãããããã®ããŒã«ã¯å¥ãããããã¯ã誰ãã圌ãã®åãä¿¡ããªããªããŸãããäœå人ãã®ç¥çãªäººã ã®ç®èŠãã¯æ¢ããããã人é¡ã®æŽå²äžæå€§ã®å€åãšãªãã§ããããéåžžèãªã¯ã¯ãã³ã®çŸ©ååã«ãããäžçã¯ãã€ãŠãªãã»ã©ç®èŠããŠããŸããçå®ãã©ãã©ãçªãæããŠããããšã§ãèªç±ã蚪ããã§ããããåæ°ãã人é¡ã®ããŒããŒãã¡ã¯ãç人ãã¡ã®èšç»ã黿¢ããäžçãããè¯ãæ¹åãžå°ãããã«ããŸããŸãå€ãã®äººã ãç«ã¡äžããã§ãããããããã®ããŒããŒã¯ãå»çé¢ä¿è ãåŒè·å£«ãç§åŠè ãæ¿æ²»å®¶ããããŠäœåãã®èŠæå¿ã®åŒ·ãåžæ°ã§ãã
ç§ãã¡ã¯çããã®å€§ããªãç®èŠãã®äžç¿Œãæ ã£ãŠããŸãã誰ããäœãããã«å芳ããŠããŠã¯ãããŸãããããã¯å ±ç¯ã§ããç¯çœªãç®æãããããèš±ãããšã¯ãç¯çœªãæ¯æããããšãšåäžã§ãã
ç§ãã¡ã®å€ãã¯ãä»äºãçµæžãå°äœãå°æ¬ãå人ãªã©ã倱ãããšãæããŠãæ²é»ãå®ã£ãŠããŸããããããä»ã声ãäžããªããã°ãä»äºãçµæžãå人ãããã¯ããã«å€ãã®ãã®ã倱ãããšã«ãªãããšãçè§£ããªããã°ãªããŸããã
Page 45
ç§ãã¡ã¯äººéæ§ã倱ããèªç«ããŠèãããæãããããããšã®ã§ããªãããã°ã©ã ããã奎é·ã«ãªã£ãŠããŸãã®ã§ããã§ã¯ãç§ãã¡ã«äœãã§ããã§ããããïŒæãéèŠãªã®ã¯ãåèã«æ å ±ãäŒããããšã§ããæåã¯ãããã¬ã³ãã«æŽè³ãããŠãããããæ¿ããæµæããããããããŸããããæåã¯æµæããããããããŸããããããã«ããããã«ãããããææ®µã䜿ã£ãŠå šäžçã®äººã ãç®èŠããããªããã°ãªããŸããã人ã ãç¡ç¥ã§ããããããããã®ç¯çœªãããã¯ãŒã¯ã¯å°çäžã«åèšããããšãã§ããã®ã ãããããä»ããã€ãŠãªãã»ã©ã®èŠéãèµ·ããŠãããç§ãã¡å šå¡ããã®èŠéã®çãçãäžããããããã«ãã§ããéãã®ããšããã矩åããããŸãã
ãã®å ±åæžãäœæãå°å·ããŠãå°å ã®èŠå¯ãåŠæ ¡ã®æ ¡é·ãæåž«ãå»çé¢ä¿è ãå人ãé£äººãªã©ã«é ãããšãã§ããŸãã
ã¿ããªã§ãã®PDFããªã³ã©ã€ã³å°å·ãµãŒãã¹ã«ã¢ããããŒãããŠãäœåéšãã®ã³ããŒãäœã£ãŠããããå°åã§é ãããšãã§ããŸãããŸãããã®ã¬ããŒããã¡ãŒã«ã«æ·»ä»ããŠãç¥ãåããæš©åè ã«éãããšãã§ããŸããç§ãã¡ã®èª°ãããäœãããªããšããèšãèš³ã¯ã§ããŸãããç§ãã¡ã¯äžçã«æ å ±ãçºä¿¡ããå¿ èŠããããŸããç§ãã¡ã¯ç«ã¡äžãããã§ããããšãããªããã°ãªããŸãããçå®ãåºãäŒããªããã°ãªããŸãããããã«ã¯åªåãå¿ èŠã§ãã座ã蟌ãã§æå¥ãèšãã®ã§ã¯ãªããç«ã¡äžãããè¡åãèµ·ãããŠãã ããããã®ã¬ããŒãã¯ãäžçãç®èŠããããããã®ããŒã«ãšãªããããå€å€§ãªåªåãæã£ãŠäœæãããŠããŸããã©ãããå©çšãã ããã
ãã詳ããæ å ±ã¯ãStopWorldControl.comãã芧ãã ãããããªãã®äººçãèªç±ããããŠæªæ¥ãå®ãããã«ãæ å ±ãšåãåŸãããã«ãå¿ ãEã¡ãŒã«ã«ç»é²ããŠãã ããã
ãããã¯ã¹Â
<ã¯ã¯ãã³ãåãã人ã«åžæã¯ããã®ãïŒ>
Stop World Controlã§ã¯ãã³ãããã»ã¯ã¯ãã³ãããããã¯ã¹ããããã®è§£æ±ºçæ¡ã調æ»ããŠããŸãããã®çµæãããã€ãã®ææãªæ¹æ³ãèŠã€ãããŸããã®ã§ãè¿æ¥äžã«ãã¯ã¯ãã³ãããã¯ã¹ã¬ã€ãããçºè¡šããããšæããŸããæ²ããããšã«ãDNAã®æ¹å€ã®ããã«ãmRNAã®æ³šå°ã«ãããã¹ãŠã®ãã¡ãŒãžãå
ã«æ»ããããã§ã¯ãããŸãããããã¯ãå
ã«æ»ãããšãã§ããªãã¹ã€ããã§ããããããäœå
ã®ãããã¯ãåãé€ãæ¹æ³ã泚å°ãããŠããçç©ãæ®ºãæ¹æ³ãã¹ãã€ã¯ã¿ã³ãã¯ãåãé€ãæ¹æ³ãªã©ã¯ãããŸããä»åŸãäºé²æ¥çš®ã¯ç¶ããããŸããŸãªç
åäœãåºãŠããã§ããããããç§ãã¡ã¯æ°ããªè§£æ±ºçããªãããç ç©¶ãç¶ããŠãããŸããã¹ãããã»ã¯ãŒã«ãã»ã³ã³ãããŒã«ã®ã¡ãŒã«ã«ç»é²ããŠããã®ç ç©¶ã®ææ°æ
å ±ãå
¥æããŠãã ããããããã¯ã¹ããããã«æå¹ãªè§£æ±ºçãããããåç¥ã®æ¹ãããããããŸãããã network@stopworldcontrol.com ã«ã¡ãŒã«ã§ãé£çµ¡ãã ããã
Page 46
ãããã«
ããŒã¿ã«ãããšãã³ãããã®æ³šå°ã§ãã§ã«æ°çŸäžäººãæ»äº¡ããŠããå¯èœæ§ããããæ°åäººãæ·±å»ãªå¯äœçšã«èŠããã§ãããšããããšãå€ã£ãŠããŸããããã¯çæçãªç Žå£ã«éããªããæ¬åœã®ç Žå£ã¯æ°å¹ŽåŸã«ãã£ãŠããŸãã
ã¯ã¯ãã³ã®äžã«ã¯é žåã°ã©ãã§ã³ãå«ãŸããŠããŸãããããã¯5Gã®å®ç§ãªäŒå°äœã§ãããšåæã«ãè³ãæäœããã®ã«æé©ãªç©è³ªã§ããããŸããããªã®å€§çµ±é ã¯ã5Gã«ãã£ãŠãã¹ãŠã®äººã«æèãææ ãæ¿å ¥ããããšè¿°ã¹ãŠããŸããã¯ã©ãŠã¹ã»ã·ã¥ã¯ãã¯ã人é¡ãäžã€ã®åãæèã«åŒãäžãããããšä»ãå ããŠããŸããããã¯ãå®å šãªãã€ã³ãã»ã³ã³ãããŒã«ã®ã¢ãžã§ã³ããæããã«ããŠããŸãããªãŒã¹ãã©ãªã¢æ¿åºã¯ããã®ã³ããã®å°å¶æ¿æ²»ããæ°äžçç§©åºããšåŒãã§ããŸãã
ãããã¯ãã¹ãŠãã³ãããã®æ°ãèšããŸãããã¹ãŠã®æ»ãã³ããããšããŠå衚瀺ããåœéœæ§ãçã¿åºãPCRæ€æ»ãè¡ããã¡ãã£ã¢ã«ããææãç œããæ¿åºã«ãããããã¬ã³ããè¡ããšããäžççãªè©æ¬ºè¡çºã«åºã¥ããŠããŸãããããã®èåŸã«ããç¯çœªãããã¯ãŒã¯ã¯ãå»çæ¥çå šäœãè²·åããŠãããäžçä¿å¥æ©é¢ãææ®ãããã¹ãŠã®äž»æµã¡ãã£ã¢ãææããã»ãšãã©ã®æ¿åºãã³ã³ãããŒã«ããŠããŸãã
圌ãã®åã¯ãåœ±ã§æŽ»åããŠããã®ã§ãäžè¬ã®äººã ã¯åœŒãã®ååšãç¥ããªããšããäºå®ããããããããŠããŸãã解決çã¯ã圌ããæŽé²ããããšãªã®ã§ããäžçäžã®ååãªæ°ã®äººã ãç¹ã«æ³å·è¡æ©é¢ãå»çåŸäºè ãåŠæ ¡ã®å çãè£å€å®ãå°æ¹èªæ²»äœãäœãèµ·ãã£ãŠããããçè§£ããã°ãéªæªãªè ãã¡ã®èšç»ã¯å€±æã«çµãããŸãã倧è¡ã®èŠéã¯ã倧è¡ããã®äžæ¯æã«ã€ãªãããŸãã
åžæ³å¶åºŠã®å€§éšåã¯è æããŠããŸãããåŒè·å£«ã¯åæ¢ãªæŠå£«ãšãªã£ãŠããã®ç¯çœªã®ãã¹ãŠã®èšŒæ ãæç€ºããå ±è¬ãããã¹ãŠã®äººã起蚎ããå¿ èŠããããŸããæµããå€ããããšãã§ããèª å®ãªè£å€å®ã¯ãŸã æ®ã£ãŠããŸãã
ç§ãã¡å
šå¡ãç«ã¡äžãããçå®ãå
±æãããããã®ç¯çœªè
ã«å¯ŸããŠäžã€ã®äººé¡ãšããŠå£çµãããªãã°ãããã¯å²äžæå€§ã®èŠéãšãªãã§ãããã
Page 47
åŒçšæç®
調æ»ã»ç ç©¶ã®åºçºç¹
ã€ã³ã¿ãŒãããã®æ€é²ãé²ã¿ãç¯çœªè ãå¿ æ»ã«ãªã£ãŠçå®ãé ãããšããŠããããã以äžã®ãªã³ã¯ã®äžéšãåé€ãããå¯èœæ§ããããŸããããããéåžžã¯ã€ã³ã¿ãŒãããã®ã¢ãŒã«ã€ãã§ãã Archive.org ãå©çšããŠããããã埩å ããããšãã§ããŸããåé€ãããURLãæ€çŽ¢ããã¯ã¹ã«ã³ããŒïŒããŒã¹ãããã ãã§ããŠã§ãããŒãžã®ä¿åçã衚瀺ãããã¯ãã§ããå人çã«ã¯ãéèŠãªWebããŒãžã¯ãã¹ãŠPDFã§ä¿åããéèŠãªãããªã¯ãã¹ãŠããŠã³ããŒãããŠãèªåã ãã®èšŒæ ããŒã¿ããŒã¹ãæ§ç¯ããŠããŸãã
1: https://renzlaw.godaddysites.com/45k-whistleblower-suit
2: https://www.icandecide.org/wp-content/uploads/2021/03/Letter-to-Dr.-Walensky-re-anaphylaxis.pdf
3: https://jamanetwork.com/journals/jama/fullarticle/2777417
4: https://centipedenation.com/first-column/150k-records-deleted-from-vaers-covid-database/
5: https://www.forbes.com/sites/emilywillingham/2015/08/06/a-congressman-a-cdc-whisteblower-and-an-autism-tempest-in-a-trashcan/?sh=47819f145396
6: https://rumble.com/vm1yrt-wow-vaccine-caused-deaths-reported-as-un-vaxxed-covid-deaths.html
7: https://dissident.one/2021/08/29/18311/
8: https://alexberenson.substack.com/p/some-actual-news
9: https://www.lifesitenews.com/news/nearly-50k-medicare-patients-died-soon-after-getting-covid-shot-whistleblower/
10: https://digital.ahrq.gov/sites/default/files/docs/publication/r18hs017045-lazarus-final-report-2011.pdf
11: https://www.facebook.com/80221381134/posts/10158207967261135/?d=n
12: https://www.dailymotion.com/video/x81f1y1
13: https://video.foxnews.com/v/6260748415001#sp=show-clips
14: https://childrenshealthdefense.org/defender/censored-dark-horse-podcast-bret-weinstein-robert-malone-inventor-mrna-vaccine-technology
15: https://rumble.com/vk894g-dr-michael-yeadon-a-final-warning-to-humanity.html
16: https://thehighwire.com/videos/a-coming-covid-catastrophe
17: https://www.youtube.com/watch?v=ZJZxiNxYLpc
18: https://doctors4covidethics.org/holocaust-survivors-write-to-the-european-medicines-agency/
19: https://healthimpactnews.com/2021/21766-dead-over-2-million-injured-50-serious-reported-in-european-unions-database-of-adverse-drug-reactions-for-covid-19-shots/
20: https://www.adrreports.eu/en/index.html
21: https://meldpuntvaccinatie.nl/
22:https://ted.europa.eu/udl?uri=TED:NOTICE:506291-2020:TEXT:EN:HTML&src=0
23: https://www.gov.uk/government/publications/coronavirus-covid-19-vaccine-adverse-reactions/coronavirus-vaccine-summary-of-yellow-card-reporting
24: https://dailyexpose.co.uk/2021/02/08/official-data-on-adverse-reactions-to-vaccines
Page 48
25: https://www.gov.uk/government/publications/coronavirus-covid-19-vaccine-adverse-reactions/coronavirus-vaccine-summary-of-yellow-card-reporting#annex-1-vaccine-analysis-print
26: https://theexpose.uk/2021/09/15/30k-people-died-within-21-days-of-having-a-covid-19-vaccine-in-england/
27: https://dailysceptic.org/is-the-mhras-yellow-card-reporting-system-safeguarding-the-uk-public
28: https://www.the-people-committee.com/
29: https://humansarefree.com/2021/08/32k-people-dead-in-brazil-following-covid-19-vaccines.html
30: https://www.salk.edu/news-release/the-novel-coronavirus-spike-protein-plays-additional-key-role-in-illness/
31: https://www.ahajournals.org/doi/10.1161/CIRCRESAHA.121.318902
32: https://www.nature.com/articles/s41586-021-03744-4
33: https://www.nejm.org/doi/full/10.1056/NEJMc2109975
34: https://deeprootsathome.com/a-foreshadowing-buried-82-miscarriage-data-in-new-nejm-study/
35: https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3897733
36: https://pubmed.ncbi.nlm.nih.gov/32908214/
37: https://citizenfreepress.com/breaking/whoa-fauci-finally-mentions-vaccine-risk-for-ade/
38: https://canadianmale.wordpress.com/2021/04/19/thousands-of-reports-of-menstrual-irregularities-reproductive-dysfunction-following-covid-vaccines/
39: https://www.lifesitenews.com/wp-content/uploads/2021/06/Pfizer-bio-distribution-confidential-document-translated-to-english.pdf
40: https://www.nature.com/articles/s41586-018-0465-8
41: https://thehighwire.com/videos/a-coming-covid-catastrophe
42: https://nulluslocussinegenio.com/2021/09/13/why-mass-vaccinations-prolong-and-make-epidemics-deadlier-real-vaccine-expert-calls-out-flawed-government-pandemic-strategy/
43: https://rumble.com/vldilx-nobel-prize-winner-professor-luc-montagnier-says-vaccine-is-creating-varian.html
44: https://rumble.com/vlme81-the-most-vulnerable-population-are-the-ones-who-received-two-vaccine-doses.html
45: https://www.bitchute.com/video/3dX3gawfhaEJ/
46: https://rumble.com/vkb885-fauci-says-cdc-considering-mask-mandates-for-vaccinated-americans.html
47: https://rumble.com/vkciqv-fauci-vaccinated-wear-a-mask-will-he-ever-be-canceled.html
48: https://rumble.com/vflkib-more-fauci-b.s.-vaccinated-americans-still-cant-eat-indoors.html
49: https://rumble.com/vlt9b1-dr.-anthony-fauci-fully-vaccinated-people-carry-as-much-virus-as-unvaccinat.html
50: https://rumble.com/vmgq6o-fauci-demands-vaccine-mandate-for-air-travel-and-public-schools.html
51: https://www.bitchute.com/video/OQBS0IAIrXEa/
52: https://www.stopworldcontrol.com/downloads/en/vaccines/vaccines-harm.pdf
53: https://www.nbcnews.com/science/science-news/cdc-warns-internal-document-war-has-changed-coronavirus-n1275478
54: https://rumble.com/vmh1er-we-need-to-prepare-to-live-with-covid-boosters-australia.html
55: https://nypost.com/2020/11/24/moderna-boss-says-covid-shot-not-proven-to-stop-virus-spread/
56: https://rumble.com/vjs9ef-australias-new-world-order-began-july-10-2021.html
57: https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3897733
58: https://www.cdc.gov/mmwr/volumes/70/wr/mm7031e2.htm?s_cid=mm7031e2_
Page 49
59: https://rumble.com/vn5us5-30000-canadian-doctors-protest-vaccine-mandates.html
60: https://newsnationusa.com/news/usanews/83000-hospital-workers-could-be-fired-as-new-york-covid-vaccine-mandate-goes-into-effect/
61: https://www.visiontimes.com/2021/06/25/the-majority-of-american-physicians-remain-unvaccinated.html
62: https://www.latimes.com/california/story/2021-06-19/vaccination-rates-lag-among-california-public-safety-workers-drawing-concern
63: https://rumble.com/vmh8gx-covid-injections-indeed-change-the-human-dna.html
63A: https://www.roxytube.com/watch/hybrid-transhuman-black-eyed-baby_Lznw1XMWmlJWQyZ.html
63B: https://www.orwell.city/2021/09/black-eyed-babies.html
64: https://rumble.com/vmk9yn-alarm-humans-with-modified-dna-have-no-rights-and-are-patented.html
65: https://www.bitchute.com/video/hy0MxQK4uQlR/
66: drrobertyoung.com/post/science-team-reveals-graphene-aluminum-lnp-capsids-peg-parasites-in-4-cov-vaccines
67: drrobertyoung.com/post/transmission-electron-microscopy-reveals-graphene-oxide-in-cov-19-vaccines
68: https://www.stopworldcontrol.com/downloads/en/vaccines/nanotech-vaccines.pdf
68A: https://rumble.com/vn482j-dr.-carrie-madej-first-u.s.-lab-examines-vaccine-vials-horrific-findings-re.html
68B: https://www.bitchute.com/video/TtgkYxzmsHSJ/
69: https://www.bitchute.com/video/UBFi2Xt4d2oR/
69A: https://www.drrobertyoung.com/post/transmission-electron-microscopy-reveals-graphene-oxide-in-cov-19-vaccines
69B: https://www.youtube.com/watch?v=s8e06KfDWMM
69C: Video Rumble XXXXXX
70: https://www.tijd.be/politiek-economie/belgie/federaal/nieuw-gemor-over-belgische-rapportering-coronadoden/10220849.html
71: https://www.bitchute.com/video/iP2eQxEwQl5h
72: https://www.stopworldcontrol.com/full
73: https://www.stopworldcontrol.com/nl/elke-de-klerk/
74: https://www.youtube.com/watch?v=g5f_6ltv7oI&t=8s
75: https://www.globalresearch.ca/hospitals-getting-paid-more-label-cause-death-coronavirus/5709720/amp
76: https://www.stopworldcontrol.com/media/
77: https://www.stopworldcontrol.com/media/
78: https://nationalfile.com/doctor-wants-to-be-scary-to-the-public-and-inflate-covid-numbers-if-you-dont-get-vaccinated-you-know-youre-going-to-die/
79: https://www.youtube.com/watch?v=UIDsKdeFOmQ
80: https://www.stopworldcontrol.com/director
81: https://educate-yourself.org/cn/flu1918andnow07feb04.shtml
82: https://salmartingano.com/2020/05/the-1918-spanish-flu-only-the-vaccinated-died/
83: https://www.sciencedirect.com/science/article/abs/pii/S1477893920302179?via%3Dihub
84: https://artsencollectief.nl / https://zelfzorgcovid19.nl/
85: https://techstartups.com/2020/04/05/new-updates-dr-vladimir-zelenko-cocktail-hydroxychloroquine-zinc-sulfate-azithromycin-showing-phenomenon-results-900-coronavirus-patients-treated-must-watch-video
Page 50
86: https://thezelenkoprotocol.com/
87:Â https://americasfrontlinedoctors.org/treatments/hydroxychloroquine/science-of-hcq
88: Â https://www.sciencedirect.com/science/article/pii/S0924857920304258 /
89: https://c19hcq.com/
90: https://ivmmeta.com
91: https://covid.us.org/2021/01/28/ivermectin-safe-effective-covid-19/
92: https://brandnewtube.com/watch/dr-mccullough-shares-is-hcq-truly-safe-for-covid-19_FoRTpkTvv6EKrlz.html
93: https://www.stopworldcontrol.com/cds
94: https://comusav.com
95: https://andreaskalcker.com
96: https://www.eldiestro.es/2021/06/del-no-tendras-nada-y-seras-feliz-pasamos-al-las-maquinas-leeran-nuestros-pensamientos-e-insertaran-incluso-sentimientos-ya-que-eso-es-algo-a-lo-que-aspiramos-todos/
97: https://www.forbes.com/sites/worldeconomicforum/2016/11/10/shopping-i-cant-really-remember-what-that-is-or-how-differently-well-live-in-2030/amp/?sh=3a2b52dd1735&__twitter_impression=true
98: https://grolltex.com/the-future-of-graphene-and-5g/
99: https://graphene-flagship.eu/innovation/spearheads/c2-sh01-5g/
100: https://www.tandfonline.com/doi/full/10.1080/03602559.2018.1542714
101: https://www.naturalnews.com/2021-07-19-graphene-based-neuromodulation-technology-is-real-inbrain-neuroelectronics.html
102: https://www.academia.edu/35846430/The_Fourth_Industrial_Revolution_Klaus_Schwab
103: https://rumble.com/vmb1vd-new-world-order-announced-by-aussie-health-overlords-then-fact-checkers-spr.html
104: https://rumble.com/vmaand-australian-health-official-talks-about-new-world-order.html
105: https://rumble.com/vlbb0g-australian-news-says-new-world-order-will-come-into-force-at-midnight.html
106: https://rumble.com/vlbay8-australian-news-broadcast-declares-new-world-order-in-effect.html
107: https://rumble.com/vjstsv-australia-new-world-order.html
108:https://www.abs.gov.au/ausstats/abs@.nsf/Lookup/by%20Subject/3303.0~2017~Main%20Features~Deaths%20due%20to%20influenza~5
109: https://www.zachvorhies.com/
110: https://www.geoengineeringwatch.org/
111: https://patents.google.com/patent/US5357865A/en
112: https://www.vaticannews.va/en/pope/news/2021-08/pope-francis-appeal-covid-19-vaccines-act-of-love.html
113: https://www.breitbart.com/national-security/2021/03/15/pope-francis-calls-for-new-world-order-after-the-pandemic/
Evidence that graphene oxide is in the vaccines:
https://stateofthenation.co/?p=70400
Page 51
https://rumble.com/vjgmj9-breaking-discovery-the-actual-contents-inside-pfizer-vials-exposed.html
https://rumble.com/vkgdq7-deadly-shots-former-pfizer-employee-confirms-poison-in-covid-vaccine.html
https://www.orwell.city/2021/07/andreas-kalcker.html
https://rumble.com/vk7lap-andreas-kalckers-team-confirms-evidence-of-graphene-oxide-in-vaccines.html
https://www.orwell.city/2021/07/absorption-signal.html